Benzodiazepine use

RX_BZD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N05BA 1 out of 7 registries used, show all original rules.	62136
4. Check minimum number of events Min. number of events 3	62136
5. Include endpoints None	62136
6. Filter based on genotype QC (FinnGen only)	62136

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	RX_BZD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N05BA
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benzodiazepine use based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	62136	37804	24332
Unadjusted period prevalence (%)	12.04	12.89	10.73
Median age at first event (years)	46.39	44.64	49.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
49566: Matched controls
369725

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

15.7

323.3

585

281

N04AA02

ATC

biperiden; systemic

16.7

323.0

2159

1005

N05BA04

ATC

oxazepam; oral

32.3

323.0

35870

27674

N04BC05

ATC

pramipexole; oral

2.5

323.0

3081

9561

N05AX12

ATC

aripiprazole; systemic

13.0

323.0

4674

2937

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

323.0

16796

89012

EBA00

NOMESCO Finland

Extraction of tooth

1.6

323.0

14720

77664

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.0

323.0

2753

7217

N06AB06

ATC

sertraline; oral

6.8

323.0

10820

14499

N05BA01

ATC

diazepam; systemic, rectal

19.2

323.0

18642

11249

R02

ICPC

Shortness of breath/dyspnoea

2.0

323.0

4962

19297

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

323.0

7279

28608

M01AE02

ATC

naproxen; oral, rectal

1.5

323.0

25684

153859

N03AG01

ATC

valproic acid; systemic, rectal

9.4

323.0

6567

5934

WX110

NOMESCO Finland

Local anesthesy

1.5

323.0

31708

199268

N02AX02

ATC

tramadol; systemic, rectal

2.0

323.0

20757

97669

A02BC01

ATC

omeprazole; systemic

2.0

323.0

13259

56484

N05CF01

ATC

zopiclone; oral

5.3

323.0

24596

57523

F39

ICD-10 Finland

Unspecified mood [affective] disorder

5.7

323.0

1212

1622

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

323.0

24714

149946

183

Kela drug reimbursment

Lamotrigin and topiramate

9.1

323.0

758

632

J01MA12

ATC

levofloxacin; systemic

1.8

323.0

7879

35341

P06

ICPC

Sleep disturbance

2.6

323.0

5251

16017

N05AA01

ATC

chlorpromazine; systemic, rectal

18.4

323.0

1499

626

N03AX16

ATC

pregabalin; oral

2.8

323.0

13622

43432

N05CF02

ATC

zolpidem; oral

4.0

323.0

12936

30129

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

323.0

3813

13238

188

Kela drug reimbursment

Psychosis requiring demanding treatment

20.0

323.0

1177

448

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

323.0

18219

100902

H02AB06

ATC

prednisolone; systemic

1.5

323.0

20346

115360

C07AB07

ATC

bisoprolol; oral

2.0

323.0

20906

99447

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

8.2

323.0

1047

974

SPAT1301

SPAT

No procedures

1.6

323.0

13403

69065

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

323.0

5358

21889

N03AF01

ATC

carbamazepine; oral, rectal

4.2

323.0

3226

6098

SPAT1307

SPAT

Psychosocial counselling and guidance

2.8

323.0

3420

9452

V03AA01

ATC

9.0

323.0

1383

1173

N06AX21

ATC

duloxetine; oral

4.7

323.0

8303

15223

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

323.0

18786

96532

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

323.0

6313

21635

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

323.0

6464

22703

SPAT1254

SPAT

Administration of medicine

2.2

323.0

6495

23704

N06AB03

ATC

fluoxetine; oral

7.0

323.0

12295

16604

N06AX16

ATC

venlafaxine; oral

6.9

323.0

14011

19856

N03AF02

ATC

oxcarbazepine; oral

3.8

323.0

1812

3641

F41.8

ICD-10 Finland

Other specified anxiety disorders

5.0

323.0

1746

2692

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

323.0

11977

58702

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

323.0

6263

25454

N05AA02

ATC

levomepromazine; systemic

18.6

323.0

5438

2429

A02BC03

ATC

lansoprazole; oral

1.9

323.0

13603

60845

Z71.8

ICD-10 Finland

Other specified counselling

1.6

323.0

10381

51847

F41.1

ICD-10 Finland

Generalized anxiety disorder

7.1

323.0

4366

4985

N03AX11

ATC

topiramate; oral

5.2

323.0

1785

2638

A02BA04

ATC

nizatidine; systemic

2.5

323.0

3486

10866

J01DA01

ATC

[U] cefalexin; systemic

1.5

323.0

28715

176292

J01FA06

ATC

roxithromycin; oral

1.5

323.0

17430

98765

M03BX02

ATC

tizanidine; oral

1.5

323.0

28365

173188

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

10.5

323.0

788

568

N06AX05

ATC

trazodone; oral

11.7

323.0

2529

1684

P16

ICPC

Acute alcohol abuse

6.0

323.0

1106

1409

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

323.0

13083

58237

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

6.9

323.0

1808

2019

N02AA05

ATC

oxycodone; systemic

2.4

323.0

6391

21614

G44.2

ICD-10 Finland

Tension-type headache

1.9

323.0

5934

24164

N05BA02

ATC

chlordiazepoxide; systemic

28.0

323.0

3029

858

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

323.0

13199

67495

N06AA04

ATC

clomipramine; systemic

15.3

323.0

1720

867

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.5

323.0

2517

5545

N06AA12

ATC

doxepin; systemic

8.5

323.0

4691

4509

P29

ICPC

Psychological sympt/compl other

4.4

323.0

4139

7541

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

323.0

7197

30364

N05AH04

ATC

quetiapine; oral

10.0

323.0

19225

22051

AA1AD

NOMESCO Finland

CT of head and brain

2.2

323.0

10863

42345

P72

ICPC

Schizophrenia

11.6

323.0

1775

1175

N05AX08

ATC

risperidone; systemic

9.5

323.0

7780

7112

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

17.5

323.0

1685

743

N05BA06

ATC

lorazepam; systemic, sublingual

29.3

323.0

6797

1995

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

7.4

323.0

2161

2260

N05AE04

ATC

ziprasidone; systemic

21.9

323.0

754

260

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

16.2

323.0

1580

752

N05CD07

ATC

temazepam; oral

9.2

323.0

12076

12499

P03

ICPC

Feeling depressed

3.0

323.0

5490

14793

K59.0

ICD-10 Finland

Constipation

2.9

323.0

2504

6605

N05AH03

ATC

olanzapine; systemic

14.2

323.0

7796

4779

N06AB04

ATC

citalopram; systemic

7.3

323.0

20897

33643

N05AF03

ATC

chlorprothixene; systemic

21.7

323.0

3538

1306

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.7

323.0

1415

1617

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

20.2

323.0

690

258

N05AD03

ATC

melperone; systemic

13.1

323.0

1122

651

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.8

323.0

7334

12951

N06AB08

ATC

fluvoxamine; oral

9.1

323.0

2493

2130

J01MA02

ATC

ciprofloxacin; systemic

1.5

323.0

16422

90004

N05AD01

ATC

haloperidol; systemic

9.9

323.0

2781

2199

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.8

323.0

1681

3360

N05AB03

ATC

perphenazine; systemic, rectal

13.1

323.0

3977

2441

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

323.0

21039

115629

N05CD02

ATC

nitrazepam; oral

11.3

323.0

1294

877

N06AX26

ATC

vortioxetine; oral

5.2

323.0

4393

6822

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

127.9

323.0

425

J01AA02

ATC

doxycycline; systemic

1.6

323.0

35528

227861

F33

ICD-10 Finland

Recurrent depressive disorder

5.0

323.0

1247

1914

N05AF01

ATC

flupentixol; systemic

14.4

323.0

1509

807

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

9.6

323.0

919

727

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

11.5

323.0

3950

2761

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

14.3

323.0

636

336

K59.09

ICD-10 Finland

Constipation, unspecified

2.8

323.0

2596

7256

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

14.9

323.0

1217

625

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.9

323.0

4480

12321

A03FA02

ATC

cisapride; oral, rectal

2.5

323.0

3388

10405

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

5.8

323.0

1855

2444

SPAT1234

SPAT

Support of social functional capacity

3.8

323.0

2443

4960

SPAT1216

SPAT

Assessment of functional ability

1.9

323.0

5604

23263

H03AA01

ATC

levothyroxine sodium; systemic

1.8

323.0

10011

45074

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.7

323.0

2601

5494

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

13.5

323.0

1483

843

IGY02

NOMESCO Finland

Psychiatric monitoring contact

7.4

323.0

1694

1769

J01FF01

ATC

clindamycin; systemic

1.6

323.0

11959

60597

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

10.6

323.0

747

535

R03BB04

ATC

tiotropium bromide; inhalant

2.2

323.0

4257

15365

N06AA09

ATC

amitriptyline; systemic

4.3

323.0

6733

12996

N05CD08

ATC

midazolam; nasal, systemic

8.4

323.0

1571

1428

N06AX22

ATC

agomelatine; oral

7.3

323.0

1755

1847

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

18.4

323.0

590

242

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.4

323.0

6090

14477

N05BE01

ATC

buspirone; oral

22.3

323.0

3716

1340

S06.0

ICD-10 Finland

Concussion

2.1

323.0

4680

17104

A04

ICPC

Weakness/tiredness general

2.1

323.0

5527

21010

P99

ICPC

Psychological disorders other

7.7

323.0

2418

2452

N03AE01

ATC

clonazepam; systemic

7.6

323.0

5279

5735

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

323.0

21884

127791

R05FB02

ATC

cough suppressants and expectorants

1.5

323.0

15646

86611

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

323.0

16858

87428

N05AF05

ATC

zuclopenthixol; systemic

18.0

323.0

1057

447

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

9.2

323.0

1044

867

J01DB01

ATC

cefalexin; oral

1.6

323.0

38024

249996

A02BC05

ATC

esomeprazole; systemic

1.8

323.0

18956

93562

L28

ICPC

Limited function/disability (L)

2.1

323.0

6145

23224

P19

ICPC

Drug abuse

9.5

323.0

772

612

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

8.4

323.0

1542

1404

N05BA09

ATC

clobazam; oral

43.4

323.0

684

119

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

14.2

323.0

972

520

N06AB05

ATC

paroxetine; oral

8.4

323.0

6393

6427

C07AB02

ATC

metoprolol; systemic

2.0

323.0

8512

35385

F32

ICD-10 Finland

Depressive episode

3.7

323.0

3352

7084

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.3

323.0

1459

2105

F31

ICD-10 Finland

Bipolar affective disorder

12.4

323.0

1169

720

A01

ICPC

Pain general/multiple sites

2.5

323.0

3425

10499

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

8.4

323.0

1197

1084

F34.1

ICD-10 Finland

Dysthymia

6.9

323.0

3012

3422

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

12.0

323.0

761

481

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

13.8

323.0

819

451

N06AX17

ATC

milnacipran; oral

8.4

323.0

871

786

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

29.0

323.0

570

148

N05AC02

ATC

thioridazine; oral

9.9

323.0

1798

1407

N05AL01

ATC

sulpiride; systemic

16.1

323.0

1447

689

P76

ICPC

Depressive disorder

4.4

323.0

4611

8387

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.9

323.0

2008

3166

IGY99

NOMESCO Finland

Other psychiatric treatment contact

7.8

323.0

1379

1347

R51.80

ICD-10 Finland

Headache

2.0

323.0

6880

28083

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

11.7

323.0

9309

7191

R42

ICD-10 Finland

Dizziness and giddiness

1.9

323.0

8962

38671

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

7.4

323.0

1996

2081

N02BE01

ATC

paracetamol; systemic, rectal

2.0

323.0

40671

258511

N06AB10

ATC

escitalopram; oral

4.9

323.0

17156

35807

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.4

323.0

1424

2025

N06AX12

ATC

bupropion; oral

6.2

323.0

5733

7612

N07BB01

ATC

disulfiram; oral

7.5

323.0

4267

4614

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.8

323.0

1734

1957

P74

ICPC

Anxiety disorder/anxiety state

6.1

323.0

3039

3891

AA400

NOMESCO Finland

Electroconvulsive therapy

21.5

323.0

900

317

F40.1

ICD-10 Finland

Social phobias

7.0

323.0

1866

2066

N05AH02

ATC

clozapine; systemic

17.0

323.0

2336

1072

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

323.0

17410

82553

N05BA12

ATC

alprazolam; oral

24.1

323.0

15426

6809

N06AG02

ATC

moclobemide; oral

8.6

323.0

4120

3834

A28

ICPC

Limited function/disability NOS

2.3

323.0

5513

19213

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

8.4

323.0

1866

1717

P15

ICPC

Chronic alcohol abuse

6.0

323.0

2124

2733

N06AA06

ATC

trimipramine; systemic

10.1

323.0

2241

1727

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

6.8

323.0

1122

1252

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

7.6

323.0

1958

1987

R06AE07

ATC

cetirizine; oral

1.5

323.0

19350

110578

F32.9

ICD-10 Finland

Depressive episode, unspecified

5.6

323.0

11097

18245

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

12.0

323.0

1963

1264

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

16.5

323.0

594

271

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

38.4

323.0

480

F22.0

ICD-10 Finland

Delusional disorder

7.3

323.0

991

1027

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

12.4

323.0

841

513

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

6.4

323.0

8344

11285

N05AN01

ATC

lithium; oral

14.4

323.0

2822

1541

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

10.0

323.0

2024

1563

A03CA02

ATC

clidinium and psycholeptics; oral

3.6

323.0

3108

6739

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

12.4

323.0

809

495

N05AB01

ATC

dixyrazine; systemic

17.2

323.0

1229

545

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

323.0

9927

40157

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

323.0

10755

52794

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

323.0

5656

22791

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

323.0

7745

33887

F20.0

ICD-10 Finland

Paranoid schizophrenia

13.3

323.0

638

361

F29

ICD-10 Finland

Unspecified nonorganic psychosis

8.8

323.0

3779

3430

F60.9

ICD-10 Finland

Personality disorder, unspecified

12.0

323.0

1394

892

P01AB01

ATC

metronidazole; oral, rectal

1.6

323.0

17926

95527

F10.20

ICD-10 Finland

Alcohol dependence currently independent

11.1

323.0

2044

1428

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.3

323.0

7068

13847

N05BA05

ATC

potassium clorazepate; oral

37.0

323.0

936

192

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

323.0

3921

13347

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

8.1

323.0

4023

3975

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

8.8

323.0

1088

940

J02AC01

ATC

fluconazole; systemic

1.6

323.0

17716

96993

F20

ICD-10 Finland

Schizophrenia

14.3

323.0

610

322

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

16.1

323.0

1148

544

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

323.0

12390

60453

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

323.0

7360

32745

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.4

323.0

3366

10923

L17

ICPC

Foot/toe symptom/complaint

1.7

323.0

10337

50066

N03AX12

ATC

gabapentin; oral

2.5

323.0

8062

26462

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

15.0

323.0

2014

1042

A02BA02

ATC

ranitidine; systemic

2.3

323.0

9723

35228

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.1

323.0

7299

27481

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

323.0

6858

30248

L03

ICPC

Low back symptom/complaint

1.8

323.0

10525

49043

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

21.5

323.0

733

258

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

7.3

323.0

6683

7758

F10.25

ICD-10 Finland

Alcohol dependence continuous use

8.4

323.0

1455

1326

R11

ICD-10 Finland

Nausea and vomiting

2.5

323.0

3629

11413

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

323.0

13244

69712

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

14.5

323.0

1122

588

R53

ICD-10 Finland

Malaise and fatigue

2.2

323.0

10047

37812

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

6.3

323.0

1708

2084

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

9.8

323.0

1454

1140

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

9.8

323.0

5166

4331

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

323.0

7391

33406

R06.0

ICD-10 Finland

Dyspnoea

1.9

323.0

10931

47009

N06AX11

ATC

mirtazapine; oral

6.1

323.0

26484

58250

B18.2

ICD-10 Finland

Chronic viral hepatitis C

11.5

323.0

1111

738

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.5

323.0

2862

8801

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

9.7

323.0

2356

1885

R03AC02

ATC

salbutamol; inhalant

1.6

323.0

24117

137247

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

12.3

323.0

2978

1907

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

20.9

323.0

567

205

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

31303

169099

F20.9

ICD-10 Finland

Schizophrenia, unspecified

13.6

323.0

2305

1324

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.8

323.0

1604

2575

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.2

323.0

1974

3642

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

323.0

12804

63974

C07AA05

ATC

propranolol; systemic

4.5

323.0

15526

33687

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.6

323.0

6680

12128

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.9

323.0

1989

3130

F32.1

ICD-10 Finland

Moderate depressive episode

3.4

323.0

3399

7838

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

7.0

323.0

5289

6243

F41.00

ICD-10 Finland

Moderate panic disorder

11.5

323.0

1592

1068

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

8.6

323.0

923

811

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.0

323.0

1884

3587

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.7

323.0

3086

6575

P01

ICPC

Feeling anxious/nervous/tense

3.6

323.0

7161

16613

M54.5

ICD-10 Finland

Low back pain

1.7

323.0

14775

74884

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

13.5

323.0

2077

1191

C03CA01

ATC

furosemide; systemic

2.0

323.0

11196

47063

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.1

323.0

5982

8159

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.6

323.0

6667

12037

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

323.0

12462

58919

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

11.1

323.0

874

595

N03AX09

ATC

lamotrigine; oral

10.3

323.0

5417

4369

M79.6

ICD-10 Finland

Pain in limb

1.6

323.0

15393

79718

J01EA01

ATC

trimethoprim; systemic

1.7

323.0

10119

49222

T36

ICD-10 Finland

Poisoning by systemic antibiotics

10.8

323.0

5077

3862

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

323.0

22126

128267

N06AX18

ATC

reboxetine; oral

10.3

323.0

963

712

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

11.7

323.0

753

485

F51.0

ICD-10 Finland

Nonorganic insomnia

3.3

323.0

8494

21937

P18

ICPC

Medication abuse

28.8

323.0

623

163

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

105.1

323.0

530

F10.24

ICD-10 Finland

Alcohol depence active use

8.7

323.0

1211

1055

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

16.3

323.0

1659

786

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

323.0

4159

14832

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

26.0

323.0

556

161

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

323.0

10490

44042

N06AX03

ATC

mianserin; oral

10.0

323.0

4685

3824

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

323.0

11620

52319

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

12.9

323.0

2127

1276

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

13.0

323.0

643

373

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

121.5

323.0

564

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

323.0

11709

44376

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

13.0

323.0

1423

836

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.7

323.0

2027

4212

F41.09

ICD-10 Finland

UNS Panic Syndrome

9.7

323.0

2809

2273

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

323.0

10339

51249

SPAT1240

SPAT

Therapeutic discussion

3.3

323.0

7251

18221

SPAT1243

SPAT

Psychiatric/psychological examination

4.2

323.0

1785

3265

A06AD11

ATC

lactulose; oral

3.2

323.0

7766

20107

F61.0

ICD-10 Finland

Mixed personality disorders

12.6

323.0

1846

1135

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

88.0

323.0

479

F31.8

ICD-10 Finland

Other bipolar affective disorders

11.4

323.0

1890

1281

E0000UV

ATC

1.5

319.3

16856

95121

M02AA07

ATC

piroxicam; topical

1.5

315.6

14568

79781

Z72.2

ICD-10 Finland

Drug use

17.3

314.9

550

240

UJF32

NOMESCO Finland

Coloscopy

1.6

313.9

10194

51296

F41.01

ICD-10 Finland

Severe panic disorder

17.0

310.9

546

242

SPAT1263

SPAT

Sampling

1.5

309.8

18208

104885

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

309.5

9435

46669

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.7

307.3

733

635

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

304.6

15568

87007

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

303.9

10543

53881

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

302.6

4144

15714

J01CA08

ATC

pivmecillinam; oral

1.5

301.8

15332

85536

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

25.3

301.1

467

139

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

300.9

4776

19192

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

300.3

14093

77265

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

299.8

3271

11212

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

299.4

31943

206030

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

298.8

8555

41550

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

297.3

6406

28610

A01AB09

ATC

miconazole; local oral

2.2

296.0

3607

13005

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

12.9

295.1

577

336

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

294.6

5545

23677

SPAT1310

SPAT

Counselling related to known health issue

1.5

294.3

13372

72715

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

88.0

292.8

363

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

11.3

292.6

609

407

L01

ICPC

Neck symptom/complaint

1.8

290.8

5685

24581

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

36.5

290.7

413

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

290.0

7860

37562

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

289.8

5203

21847

K02.1

ICD-10 Finland

Caries of dentine

1.4

288.2

25573

158704

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

286.6

16991

97582

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.3

286.5

1638

3816

N05CD05

ATC

triazolam; oral, sublingual

7.5

285.4

746

751

N30.0

ICD-10 Finland

Acute cystitis

1.9

285.3

5220

22056

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

284.2

2655

8413

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.8

282.6

2060

5662

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

282.2

4776

19623

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

282.2

4611

18705

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

7.6

282.2

730

723

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.2

280.9

972

1422

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

15.0

280.2

515

258

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

15.1

279.2

512

255

SPAT1260

SPAT

Consultation of another employee

1.7

277.7

7281

34421

G04BD04

ATC

oxybutynin; oral, transdermal

2.7

277.2

2108

5947

P28

ICPC

Limited function/disability (P)

9.5

276.2

626

495

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

276.0

6557

30112

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.3

275.9

1148

2040

S18

ICPC

Laceration/cut

1.4

275.7

16773

96613

C08CA01

ATC

amlodipine; oral

1.5

274.9

12695

69060

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

274.1

8325

40961

IGV01

NOMESCO Finland

Psychiatric network contact

10.8

273.9

581

404

R41.0

ICD-10 Finland

Disorientation, unspecified

3.8

272.8

1279

2537

C10AA01

ATC

simvastatin; oral

1.5

272.7

15322

86811

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

5.0

272.4

976

1485

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

271.5

8843

44288

A10BA02

ATC

metformin; oral

1.5

270.1

10392

54201

R52.2

ICD-10 Finland

Other chronic pain

3.2

269.3

1590

3791

N06AA22

ATC

13.5

269.1

517

289

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

13.0

268.9

524

303

N06BA04

ATC

methylphenidate; oral

3.9

268.8

1232

2395

D01

ICPC

Abdominal pain/cramps general

1.9

267.0

4487

18367

F21

ICD-10 Finland

Schizotypal disorder

11.2

266.0

555

373

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

12.1

265.4

534

332

M01AH01

ATC

celecoxib; oral (coxibs)

1.7

264.9

7068

33533

M01AB05

ATC

diclofenac; systemic, rectal

1.4

264.7

29448

188960

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

10.6

263.6

565

401

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

263.0

2825

9593

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.9

262.8

729

802

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

261.7

6743

31666

F41.3

ICD-10 Finland

Other mixed anxiety disorders

5.5

261.6

856

1172

F32.8

ICD-10 Finland

Other depressive episodes

5.0

260.0

921

1383

T90

ICPC

Diabetes non-insulin dependent

1.6

259.9

8476

42399

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

259.3

22364

136952

SPAT1229

SPAT

Assessment of need for aid

2.2

259.2

2907

10072

WX290

NOMESCO Finland

Other blockade of nerve

1.4

258.8

19917

119482

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

11.8

257.5

524

334

F41

ICD-10 Finland

Other anxiety disorders

5.1

257.4

901

1335

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

256.5

7168

34417

G47.3

ICD-10 Finland

Sleep apnoea

1.6

254.6

8801

44641

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

254.2

23253

143678

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

252.5

4065

16362

M01AX17

ATC

nimesulide; oral

1.5

250.7

9409

48652

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

14.8

249.6

461

234

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

248.1

5647

25530

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

246.7

5405

24147

SPAT1252

SPAT

Overall medication plan or its review

2.3

245.2

2670

9116

F61

ICD-10 Finland

Mixed and other personality disorders

13.6

245.0

469

260

F60.8

ICD-10 Finland

Other specific personality disorders

9.6

244.9

552

432

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

36.5

242.9

345

D11

ICPC

Diarrhoea

1.8

242.9

4771

20571

SPAT1265

SPAT

Breathalyser

6.5

242.8

696

802

K08.3

ICD-10 Finland

Retained dental root

2.2

242.7

2908

10373

R07.3

ICD-10 Finland

Other chest pain

2.0

242.1

3704

14612

A02BX02

ATC

sucralfate; oral

2.8

242.0

1737

4722

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

240.7

7665

38021

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

240.3

3635

14276

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.3

239.2

1359

3147

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

237.3

13872

78683

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

21.1

237.0

387

138

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.9

236.2

1084

2108

M79.7

ICD-10 Finland

Fibromyalgia

3.0

235.2

1544

3959

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

235.1

3321

12693

N03AX14

ATC

levetiracetam; systemic

3.4

234.4

1267

2824

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

32.7

233.9

340

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

233.3

9340

48905

R52.9

ICD-10 Finland

Pain, unspecified

2.0

233.0

3411

13219

M79.1

ICD-10 Finland

Myalgia

1.7

232.7

5252

23645

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

231.8

4907

21658

F20.10

ICD-10 Finland

Raise schizophrenia continuously

18.0

230.9

397

166

A07AA02

ATC

nystatin; oral

2.3

230.3

2407

8051

N06AA10

ATC

nortriptyline; systemic

3.7

229.7

1114

2273

R50.9

ICD-10 Finland

Fever, unspecified

1.7

229.5

5692

26349

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

228.8

16944

100234

F05.9

ICD-10 Finland

Delirium, unspecified

4.6

228.2

888

1475

N07BA03

ATC

varenicline; oral

2.3

226.6

2412

8138

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

226.4

10946

59655

R00.2

ICD-10 Finland

Palpitations

2.1

226.3

2947

10886

Z72.1

ICD-10 Finland

Alcohol use

5.3

225.4

769

1106

F20.5

ICD-10 Finland

Residual schizophrenia

13.0

224.5

438

254

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.9

224.5

1535

4043

N05AC01

ATC

periciazine; systemic

17.4

224.5

390

168

A29

ICPC

General symptom/complaint other

1.8

224.4

4196

17769

P98

ICPC

Psychosis NOS/other

8.7

221.2

527

456

N05AB02

ATC

fluphenazine; systemic

13.4

220.8

425

239

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

220.7

5019

22625

Z00.0

ICD-10 Finland

General medical examination

1.6

220.2

7365

36892

P80

ICPC

Personality disorder

12.6

220.1

435

260

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

219.9

1791

5250

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

219.7

8144

41813

L02

ICPC

Back symptom/complaint

1.9

219.6

3678

14982

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.9

219.5

794

1220

H02AB07

ATC

prednisone; oral

1.7

219.4

5674

26554

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

218.9

3024

11442

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

20.7

218.8

359

130

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

218.6

3931

16419

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

218.6

5835

27549

T74.1

ICD-10 Finland

Physical abuse

3.8

218.5

1041

2092

A06AC51

ATC

ispaghula, combinations; systemic

2.4

218.1

2041

6454

D12

ICPC

Constipation

3.1

218.0

1349

3321

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

217.6

11412

63139

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

27.9

216.6

327

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

215.8

12556

70866

P73

ICPC

Affective psychosis

12.4

215.0

427

258

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

215.0

8331

43188

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

214.9

3320

13119

R05

ICPC

Cough

1.5

214.6

8790

46141

UKC02

NOMESCO Finland

Cystoscopy

1.6

214.5

6043

28940

N02AC04

ATC

dextropropoxyphene; oral

2.8

213.7

1526

4132

V03AB30

ATC

9.0

213.5

498

415

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.8

213.5

1542

4204

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

213.4

4261

18424

F33.8

ICD-10 Finland

Other recurrent depressive disorders

7.2

211.9

566

589

U02

ICPC

Urinary frequency/urgency

1.7

210.8

4719

21151

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

210.2

10944

60384

X78

ICD-10 Finland

Intentional self-harm by sharp object

9.9

208.3

462

351

F60.7

ICD-10 Finland

Dependent personality disorder

15.1

208.2

381

189

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

32.5

208.2

303

D07AC01

ATC

betamethasone; topical

1.4

207.9

13737

79265

P20

ICPC

Memory disturbance

1.9

207.4

3457

14046

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

87.6

207.4

257

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.8

206.7

970

1923

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

12.4

206.4

411

250

S01.0

ICD-10 Finland

Open wound of scalp

2.0

206.3

2894

11009

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.6

205.9

1629

4692

H02AB04

ATC

methylprednisolone; systemic

1.6

205.7

5737

27375

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

205.5

4081

17603

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

204.3

10549

58048

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

204.1

3894

16575

R60.0

ICD-10 Finland

Localized oedema

1.8

201.5

3862

16461

WX002

NOMESCO Finland

Sedation and analgesia

1.5

201.4

7390

37761

K30

ICD-10 Finland

Functional dyspepsia

1.8

201.2

4072

17670

E000001

ATC

1.5

201.1

8376

44043

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

201.0

7685

39640

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

10.6

200.8

429

303

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

14.3

200.1

374

196

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

13.4

199.6

383

214

C07AB03

ATC

atenolol; systemic

2.3

199.5

2121

7142

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

6.6

199.2

568

650

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

198.6

2704

10157

30041

ICD-8 Finland

Neuroses, Depressiva

5.7

198.4

634

843

C05AA08

ATC

fluocortolone; rectal, topical

1.6

198.3

5602

26801

U04

ICPC

Incontinence urine

2.6

198.1

1577

4557

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

197.2

2012

6641

A07DA03

ATC

loperamide; oral

2.7

196.6

1501

4233

IGY02

SPAT

8.3

196.1

480

435

N17

ICPC

Vertigo/dizziness

1.8

196.0

3824

16389

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

10.1

195.6

429

319

SPAT1312

SPAT

General health counselling

1.4

195.3

13045

75229

G04BD07

ATC

tolterodine; oral

2.5

195.3

1770

5498

M48.0

ICD-10 Finland

Spinal stenosis

1.8

195.2

4015

17503

S29

ICPC

Skin symptom/complaint other

1.6

193.4

6253

30957

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044889) 12 lead EKG panel

37799

233190

1.40

319.12

4.3

3.5

—

(3015736) pH of Urine

22962

130305

1.41

316.72

4.0

3.2

5.82

5.74

0.19

(3021589) Normoblasts [#/volume] in Blood

25948

150756

1.39

309.28

11.7

9.0

0.00

e9/l

0.61

21328

123957

(3002582) Erythrocytes [#/volume] in Urine

19005

99064

1.53

307.65

3.6

3.1

64.71

94.23

e6/l

2.78

14812

75475

(3011288) Drugs identified in Urine by Screen method

3948

8464

3.48

307.65

5.7

2.1

—

(3042517) Benzodiazepines panel - Urine

482

107

32.29

307.65

3.4

1.5

—

(3019225) pH of Specimen

7345

29848

1.85

307.65

4.4

4.1

—

(3033658) Prothrombin time (PT) actual/Normal

16210

83677

1.51

307.65

4.5

3.8

91.37

90.75

2.28

15687

81585

(3019309) Folate [Moles/volume] in Red Blood Cells

14790

55227

2.19

307.65

1.9

1.7

1187.86

1159.22

nmol/l

2.93

11029

42202

(3009508) Creatinine [Moles/volume] in Urine

19085

100529

1.51

307.65

3.6

3.2

7.17

7.98

mmol/l

7.08

15707

85244

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

44917

264128

1.80

307.65

5.0

3.8

14.59

14.71

pmol/l

19.09

40787

241980

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1045

1526

4.94

307.65

3.3

2.6

21.10

26.91

ug/l

—

(3028707) Methadone [Presence] in Urine by Screen method

3393

4579

5.52

307.65

4.5

2.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1191

2294

3.75

307.65

1.8

1.3

1.46

1.36

promille

1.16

877

1805

(3014111) Lactate [Moles/volume] in Serum or Plasma

6459

27014

1.78

307.65

6.5

7.2

1.39

1.35

mmol/l

2.15

6152

26069

(3026008) Bacteria identified in Urine by Culture

19629

95724

1.68

307.65

3.6

2.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

2178

5922

2.68

307.65

2.8

2.7

33.71

33.97

umol/l

0.15

1850

4996

(1001926) Buprenorphine [Presence] in Urine by Screen method

4035

10166

2.95

307.65

4.3

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

17546

80562

1.77

307.65

2.4

2.2

2.97

2.91

mg/l

2.77

14743

69150

(3013512) EKG study

17925

90125

1.59

307.65

4.3

3.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

16316

70723

1.88

307.65

1.6

1.5

20.38

20.28

nmol/l

0.32

14025

61125

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

17141

85982

1.58

307.65

3.1

2.9

1305.13

1410.17

ng/l

2.19

14231

73176

(3015377) Calcium [Moles/volume] in Serum or Plasma

23415

105778

1.93

307.65

3.3

2.35

mmol/l

0.00

20133

93000

(3018010) Neutrophils/100 leukocytes in Blood

29219

162152

1.54

307.65

6.9

5.7

57.66

57.14

10.86

27067

152326

(3027008) Opiates [Presence] in Urine

4436

13875

2.37

307.65

4.2

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1818

866

15.36

307.65

13.4

867.57

1897.97

nmol/l

0.43

1756

835

(3002030) Lymphocytes/100 leukocytes in Blood

29684

164551

1.55

307.65

7.1

5.9

27.64

28.20

14.73

27423

153895

(3012095) Magnesium [Moles/volume] in Serum or Plasma

11920

50456

1.85

307.65

3.4

0.81

0.82

mmol/l

11.27

10977

47155

(3009343) pH of Capillary blood

5053

18653

2.01

307.65

3.8

3.4

7.42

0.00

734

2422

(40758558) Short blood count panel - Blood

16429

83424

1.55

307.65

8.6

6.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7864

28711

2.09

307.65

2.2

366.99

376.37

nmol/l

3.42

7104

26595

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9367

40551

1.76

307.65

5.3

6.1

1.03

1.04

mmol/l

3.03

8628

37898

(3018418) pH of Serum or Plasma

19829

93171

1.76

307.65

4.2

4.1

7.40

0.22

4113

17491

(3001604) Monocytes [#/volume] in Blood

31046

168357

1.63

307.65

6.9

5.7

0.59

0.58

e9/l

8.91

26966

146358

(3006504) Eosinophils/100 leukocytes in Blood

29065

158454

1.58

307.65

7.0

5.9

2.72

2.87

23.21

26894

148121

(3019198) Lymphocytes [#/volume] in Blood

31697

174035

1.62

307.65

7.0

5.7

1.94

1.93

e9/l

0.69

27889

154122

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

22285

117374

1.55

307.65

3.6

3.2

0.51

0.23

e6/l

—

(3013707) Erythrocyte sedimentation rate by Westergren method

42046

252061

1.60

307.65

4.5

3.9

12.56

11.52

mm/h

38.26

38512

234590

(3028300) Cannabinoids [Presence] in Urine

4451

13908

2.38

307.65

4.3

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

33605

169686

1.91

307.65

6.7

5.9

10.26

11.49

umol/l

55.21

31508

160763

(4198724)

1013

1086

6.73

307.65

2.7

1.9

—

(3032080) INR in Blood by Coagulation assay

24798

129014

1.62

307.65

9.0

8.5

1.19

1.24

inr

7.76

7697

37501

(40768797) Stomach Pathology biopsy report

9575

44083

1.65

307.65

1.3

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

39901

235909

1.59

307.65

5.1

4.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

854

1008

6.10

307.65

2.3

1.7

146.73

122.26

umol/l

0.97

420

515

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1674

970

12.60

307.65

12.4

11.6

0.62

mmol/l

0.15

1526

905

(3006315) Basophils [#/volume] in Blood

31227

169125

1.64

307.65

7.0

5.7

0.04

e9/l

0.10

27080

147003

(3009466) Valproate [Moles/volume] in Serum or Plasma

3244

2823

8.58

307.65

5.9

4.3

376.67

357.53

umol/l

6.51

2854

2404

(42870588) Differential panel, method unspecified - Blood

22564

112870

1.67

307.65

6.3

5.9

—

(3018095) Leukocytes [#/volume] in Urine

21884

117168

1.51

307.65

4.2

3.5

92.74

96.24

e6/l

0.22

15802

81732

(3019069) Monocytes/100 leukocytes in Blood

29216

159318

1.58

307.65

7.3

6.1

8.44

8.53

4.87

27163

149721

(3030467) Casts [#/volume] in Urine by Automated count

17500

90361

1.53

307.65

3.5

3.0

0.43

0.40

e6/l

0.63

13371

67467

(3031040) Bacteria [#/volume] in Urine by Automated count

39537

222764

1.75

307.65

5.7

4.1

1932.49

1226.14

e6/l

1.23

578

3075

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4899

18008

2.02

307.65

3.8

3.4

1.79

1.63

mmol/l

2.05

3742

13073

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

20784

95336

1.84

307.65

2.5

2.0

244.20

201.90

u/l

3.03

19410

89580

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5661

22575

1.86

307.65

1.7

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

26469

135643

1.69

307.65

2.5

2.2

76.27

742.29

nmol/l

0.50

23674

123157

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

11660

49980

1.82

307.65

2.0

1.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

935

548

12.31

307.65

2.5

2.3

151.74

147.95

nmol/l

0.25

816

470

(3013115) Eosinophils [#/volume] in Blood

32078

174733

1.65

307.65

7.6

5.9

0.19

e9/l

7.24

28118

154216

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7766

34328

1.70

307.65

1.9

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

27092

152069

1.48

307.65

3.2

2.8

121.11

120.41

ug/l

0.12

24615

142159

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

39197

234605

1.53

307.65

4.3

2.8

54.61

45.57

u/l

52.66

36324

220719

(3000850) Epithelial cells [#/volume] in Urine

13894

68148

1.58

307.65

2.8

2.5

6.81

5.47

e6/l

10.30

12166

59435

(3026782) Osmolality of Urine

13274

63117

1.63

307.65

3.0

2.7

504.94

555.56

mosm/kgh2o

108.88

11335

53727

(36304419) Bacteria [Presence] in Urine

17121

88314

1.53

307.65

3.4

3.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

45701

257336

2.05

307.65

8.7

7.2

78.80

77.22

u/l

9.78

42942

242635

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

26993

129397

1.87

307.65

2.2

1.9

97.09

95.91

pmol/l

3.30

14093

68687

(3022096) Basophils/100 leukocytes in Blood

28316

153514

1.58

307.65

7.0

5.9

0.65

0.68

10.84

26207

143566

(3013650) Neutrophils [#/volume] in Blood by Automated count

35305

194664

1.69

307.65

12.4

8.4

4.26

4.09

e9/l

31.41

31089

170225

(3016879) Cocaine [Presence] in Urine

4342

12641

2.55

307.65

4.2

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22477

110033

1.72

307.65

3.8

3.1

34.37

33.13

u/l

0.77

21031

104586

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7048

29782

1.77

307.65

2.8

2.5

37.87

46.57

u/l

1.42

5958

25587

(3019550) Sodium [Moles/volume] in Serum or Plasma

54165

351909

1.85

307.65

21.9

14.4

139.27

139.69

mmol/l

226.85

52839

342929

(3000764) Benzodiazepines [Presence] in Urine

4442

13770

2.40

307.65

4.2

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7797

34123

1.72

307.65

1.9

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2269

5687

2.91

307.65

1.6

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

54209

353013

1.83

307.65

21.9

14.5

3.96

mmol/l

0.71

52808

343322

(3027944) Amphetamines [Presence] in Urine

4211

13776

2.26

307.65

4.0

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

35685

194130

1.74

307.65

5.5

4.5

6.66

6.69

mmol/l

1.10

33719

179750

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12642

55907

1.77

307.65

3.1

3.0

2.45

mmol/l

0.94

10910

48771

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

30268

142123

2.02

307.65

6.3

5.9

1.21

mmol/l

1.56

27327

129007

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

12038

40468

2.39

307.65

2.4

1.6

1.57

1.40

97.87

10440

36091

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

22361

102494

1.87

307.65

3.0

2.5

54.94

58.87

u/l

13.24

20346

94896

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5123

18889

2.01

307.65

3.9

3.4

5.23

5.12

kpa

15.11

4732

17444

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

24152

120550

1.70

307.65

4.4

3.3

68.67

61.48

ng/l

0.23

16529

77111

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

50342

316732

1.75

307.65

6.1

4.5

1.89

2.10

mu/l

3.51

46228

292600

(3024561) Albumin [Mass/volume] in Serum or Plasma

28186

139038

1.82

307.65

4.9

4.8

35.45

35.71

g/l

11.21

25884

129182

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

32469

157936

1.99

307.65

7.0

6.5

1.21

mmol/l

0.14

27011

133463

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6932

28887

1.80

307.65

2.4

2.2

0.22

0.21

g/l

0.13

6343

26925

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

14629

66412

1.75

307.65

1.7

1.6

24799639.31

37461800.98

pmol/l

1.93

11827

55660

(3023368) Bacteria identified in Blood by Culture

18552

84804

1.80

307.65

4.8

4.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

14284

73885

1.49

307.65

1.9

1.7

1.15

1.19

mg/l

0.67

10634

56210

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1905

925

15.09

307.65

18.2

19.4

1994.01

3738.97

nmol/l

0.44

1824

881

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4637

18223

1.88

306.72

1.6

1.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

10472

51345

1.54

304.09

2.4

2.5

12.82

13.76

umol/l

1.67

9486

47751

(3003181) Sodium [Moles/volume] in Urine

1729

4532

2.76

299.34

1.4

58.02

64.45

mmol/l

7.29

1289

3641

(21494755) Public health laboratory ask at order entry panel

2999

41057

0.49

297.31

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9731

47165

1.56

296.63

2.4

2.5

2.38

2.34

g/l

5.66

8765

43742

(3003396) Base excess in Arterial blood by calculation

7681

35240

1.63

294.74

7.1

7.3

1.27

0.97

mmol/l

7.86

6196

27477

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

866

1454

4.28

294.02

2.4

1.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

7670

35224

1.63

293.02

7.1

7.4

11.73

12.65

kpa

43.90

7330

33550

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7671

35248

1.63

292.36

7.1

7.4

5.18

5.06

kpa

19.68

7333

33584

(3022217) INR in Platelet poor plasma by Coagulation assay

8536

40449

1.58

285.91

22.7

23.6

1.30

1.35

inr

2.25

1275

5755

(3002032) Base excess in Venous blood by calculation

6428

28407

1.68

284.38

3.9

4.0

1.97

1.80

mmol/l

2.71

5232

23257

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2992

10368

2.11

281.33

2.2

2.4

433.77

557.15

ug/l

1.46

2771

9692

(3012544) pH of Venous blood

6613

29530

1.67

281.05

3.8

4.0

7.39

0.00

146

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6428

28516

1.67

280.03

3.9

4.0

5.92

5.81

kpa

13.63

6169

27731

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7963

37302

1.60

279.39

2.9

2.7

7.59

8.58

umol/l

3.63

6550

32508

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4406

17578

1.84

276.88

1.8

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

47931

311178

1.45

276.64

6.5

5.3

39.60

39.38

mmol/mol

5.20

43774

290191

(3000991) Gas panel - Venous blood

5934

25860

1.70

275.97

7.7

8.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

11958

61515

1.48

272.28

4.2

3.5

248.83

541.85

ng/l

13.32

8629

45900

(3027945) Reticulocytes/100 erythrocytes in Blood

7415

34397

1.61

270.17

2.5

1.82

1.74

7.96

6361

30581

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6966

31866

1.63

268.49

4.2

3.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8996

43752

1.54

267.07

2.5

2.6

21.84

23.09

12.83

7647

37399

(3044640) Blood type and Crossmatch panel - Blood

18987

106597

1.39

265.74

2.6

2.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

8219

39242

1.57

264.57

1.9

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

898

1687

3.83

263.57

1.8

1.3

—

(3022313) Gas panel - Capillary blood

3555

13429

1.94

263.33

4.0

3.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

52739

349824

1.53

262.71

19.5

12.8

22.99

23.31

mg/l

1.33

44315

274186

(3014576) Chloride [Moles/volume] in Serum or Plasma

8189

39324

1.56

256.30

7.3

7.1

103.88

104.59

mmol/l

27.49

7992

38482

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

49486

324554

1.45

253.96

17.1

11.9

83.47

83.48

ml/min/173m2

0.01

41689

266550

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

740

1242

4.28

251.31

1.9

1.4

2119145.76

1382330.21

iu/ml

0.81

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

14187

76503

1.42

247.40

1.3

1.35

1.70

u/ml

2.74

3540

21335

(3024354) Oxygen [Partial pressure] in Venous blood

5331

23245

1.69

245.81

3.4

3.3

4.74

4.60

kpa

4.00

5075

22521

(3042936) Bacteria identified in Isolate by Culture

9297

46286

1.51

245.40

2.2

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

28007

168606

1.34

243.36

4.3

3.4

0.00

estimate

2.93

5915

31019

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

14749

80368

1.40

241.14

2.5

2.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3684

14489

1.86

240.95

3.9

4.4

24.24

24.09

mmol/l

1.88

3278

13037

(3007164) IgA [Mass/volume] in Serum or Plasma

12494

66236

1.43

238.03

1.5

1.4

2.39

2.38

g/l

0.10

7123

41484

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3118

11652

1.95

237.64

4.2

3.7

24.91

24.75

mmol/l

2.27

2903

10753

(3021601) Nitrite [Presence] in Urine by Test strip

27988

169040

1.33

234.28

5.6

4.6

0.00

estimate

0.47

6013

31859

(3009261) Glucose [Presence] in Urine by Test strip

28247

170832

1.33

234.26

4.4

3.4

0.00

estimate

2.31

5901

30901

(3016502) Oxygen saturation in Arterial blood

6741

31577

1.58

233.16

7.5

7.7

95.05

95.81

16.21

6538

30335

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7996

38957

1.53

232.36

8.3

6.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4442

18725

1.74

230.64

6.6

7.3

24.96

24.69

mmol/l

4.68

4385

18563

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

50119

330932

1.43

229.89

5.3

4.2

6.02

5.87

mmol/l

105.17

45310

305086

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4862

21039

1.70

229.80

3.0

3.4

4.37

4.53

pmol/l

17.50

4135

18981

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5652

25521

1.63

226.94

4.2

3.7

1.23

mmol/l

0.95

4845

22380

(3029937) Albumin [Presence] in Urine by Test strip

16114

90251

1.37

218.91

4.9

3.8

0.00

estimate

1.12

5841

30563

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

318

251

9.06

217.98

1.2

1.1

—

(3010421) pH of Blood

2313

8050

2.09

213.93

4.4

3.7

7.42

2.83

1988

6833

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2464

8801

2.03

212.64

1.4

276.16

274.66

ug/g

0.10

1391

5086

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7785

38659

1.50

204.37

4.6

4.2

31.46

32.24

7.46

5328

27173

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5604

25953

1.59

201.51

2.5

2.2

6.04

7.51

ug/l

4.64

4602

22775

(3018677) aPTT in Platelet poor plasma by Coagulation assay

9516

49302

1.44

200.82

2.1

29.77

29.79

0.10

9187

47888

(3012501) Base excess in Blood by calculation

2047

6981

2.12

199.33

4.5

3.8

2.58

2.46

mmol/l

1.00

1423

4637

(3013290) Carbon dioxide [Partial pressure] in Blood

2047

6983

2.12

199.18

4.5

3.8

5.06

4.98

kpa

4.80

1986

6829

(3048689) Calprotectin [Mass/mass] in Stool

8400

42554

1.47

199.17

2.3

2.4

136.52

132.13

ug/g

0.48

6340

33773

(3019060) Gas panel - Arterial blood

4553

20082

1.66

199.01

4.9

4.8

—

(3023520) Reticulocytes [#/volume] in Blood

5473

25288

1.59

198.54

2.4

2.7

71.56

69.26

e9/l

4.29

4089

19071

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

10526

55651

1.42

198.45

3.0

2.7

1.48

1.10

e6/l

0.76

5868

31557

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

9923

51917

1.43

198.26

3.2

2.8

3.44

2.87

e6/l

4.31

5287

28027

(3027315) Oxygen [Partial pressure] in Blood

2053

7028

2.12

197.97

4.5

3.8

8.65

8.67

kpa

0.24

1992

6873

(3008295) Osmolality of Serum or Plasma

1055

2643

2.87

197.88

1.5

277.75

280.23

mosm/kgh2o

2.27

792

2086

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3230

12982

1.81

195.95

2.1

1.9

—

(3019150) Specific gravity of Urine by Refractometry

13263

73081

1.37

195.32

4.8

3.7

1.02

kg/l

0.87

1922

11114

(3020779) Urea [Moles/volume] in Serum or Plasma

5870

27684

1.56

194.82

6.9

7.7

9.10

9.83

mmol/l

11.90

5546

26328

(1616796) Gas panel - Central venous blood

2010

6898

2.11

192.52

4.0

3.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2985

11817

1.84

189.99

2.0

1.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

254

184

9.86

184.38

7.0

7.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6066

29313

1.52

179.48

8.0

8.1

121.93

121.76

g/l

0.26

5899

28211

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2113

7645

2.00

175.50

3.2

2.9

25.05

24.50

mmol/l

6.47

1860

6738

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3720

16083

1.69

174.47

8.5

9.7

24.44

24.26

mmol/l

2.50

3417

15050

(3011397) Hemoglobin [Presence] in Urine by Test strip

13854

78103

1.34

172.09

4.2

3.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4938

23037

1.57

170.56

3.3

4.0

86.18

92.03

ng/l

3.61

4143

20051

(3012516) Albumin [Mass/volume] in Urine

16127

93037

1.32

170.31

3.2

3.3

416.98

416.64

mg/l

0.00

9791

59580

(40767503) Oxygen content in Capillary blood by calculation

1854

6518

2.06

166.42

2.8

2.4

16.56

16.52

0.14

969

3359

(3000494) Fungus identified in Specimen by Culture

7479

38294

1.44

164.87

1.5

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2254

8531

1.91

164.30

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

16801

98035

1.30

161.32

4.0

9.89

9.34

mg/mmol

0.58

10004

63019

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3171

36113

0.60

156.46

1.8

1.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

5183

24990

1.52

153.54

2.4

2.5

66.24

66.59

g/l

2.46

4612

22822

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4201

19351

1.58

152.46

8.7

9.3

1.55

1.35

20.55

4179

19213

(3028626) Oxygen [Partial pressure] in Capillary blood

1892

6916

1.98

152.43

3.3

3.0

8.24

8.30

kpa

0.77

1755

6435

(3017143) Hepatitis C virus Ab [Presence] in Serum

8066

42429

1.41

151.98

1.7

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

4199

19401

1.58

150.33

8.8

9.5

93.25

94.02

11.36

4183

19329

(3028271) Lactate [Moles/volume] in Capillary blood

1443

4798

2.17

149.39

2.1

1.8

1.72

1.74

mmol/l

0.32

1415

4678

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4180

19341

1.58

148.66

8.7

9.4

0.68

0.67

0.21

4162

19215

(3017181) Myelocytes/100 leukocytes in Blood

5607

27762

1.48

145.68

4.3

4.1

0.91

0.95

0.48

1762

7430

(3007463) Buprenorphine [Presence] in Urine

146

18.26

145.27

9.8

3.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

13516

77583

1.31

143.09

5.4

4.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7025

36469

1.42

141.82

3.7

4.2

234.51

243.41

u/l

5.43

6533

34569

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1665

22032

0.52

141.77

1.4

1.5

—

(3020891) Body temperature

2828

12055

1.70

138.86

5.3

4.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1274

4155

2.21

138.24

1.7

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1775

6569

1.95

137.90

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1775

6573

1.95

137.66

1.4

1.3

—

(40761536) Microorganisms panel - Urine sediment

5737

28877

1.46

136.51

4.7

3.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

4263

20271

1.53

133.78

2.2

2.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

5311

26463

1.47

132.96

4.3

4.1

0.12

0.13

0.71

1618

6902

(3025941) Bacteria identified in Stool by Culture

4168

19786

1.54

131.73

1.3

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

5100

25256

1.48

131.64

4.0

3.9

0.59

0.66

1.26

1261

5380

(3018405) Lactate [Moles/volume] in Arterial blood

2515

10578

1.72

129.45

4.3

4.2

1.39

1.38

mmol/l

0.23

2484

10379

(3037522) Nuclear Ab [Titer] in Serum

8653

47154

1.36

129.34

1.4

1.3

493.57

547.68

titre

1.95

1716

9460

(3021901) Oxygen saturation in Capillary blood

1549

5592

2.00

129.07

2.9

2.7

—

(1761868) Lipid panel - Serum or Plasma

15542

131194

0.79

127.16

3.0

2.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3173

14292

1.61

125.60

3.3

2.9

1.52

1.24

24.92

3159

14216

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2742

11940

1.66

124.03

2.1

2.0

2.04

2.30

ug/l

0.56

2365

10558

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4055

19434

1.52

122.28

7.6

7.0

25.00

24.50

mmol/l

13.26

3842

18058

(3005719) IgG [Mass/volume] in Serum or Plasma

4981

24923

1.46

121.45

2.5

2.7

10.30

10.63

g/l

6.10

4491

22857

(3022806) Fractional oxyhemoglobin in Capillary blood

1175

3913

2.16

121.08

2.1

1.7

89.78

89.89

0.25

1155

3854

(3052851) Hemolysis interference index of Serum or Plasma

2299

9633

1.73

119.79

3.3

3.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

467

967

3.45

119.49

3.1

2.7

29.70

28.05

umol/l

1.63

343

741

(40761535) Cells panel - Urine sediment

5192

26262

1.44

119.47

3.8

3.4

—

(4010399)

4678

23214

1.47

118.89

1.5

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

21337

131650

1.24

118.62

4.7

3.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3079

14017

1.59

116.40

3.2

2.9

0.66

0.49

2957

13458

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1993

8110

1.77

114.89

1.3

491.09

546.85

mg/l

2.31

1887

7741

(3016038) Potassium [Moles/volume] in Urine

653

1706

2.74

113.49

1.2

30.16

35.59

mmol/l

7.26

538

1483

(3022145) Colonoscopy Study observation

6945

37341

1.36

111.61

1.3

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

7546

41197

1.35

109.69

2.3

2.0

—

(3025159) Blasts/100 leukocytes in Blood

4928

25073

1.43

109.36

4.4

4.2

0.16

0.22

0.46

1351

5858

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

25680

162616

1.21

106.86

4.3

4.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2903

13295

1.58

106.79

1.8

1.6

408.75

290.39

mu/l

13.15

2550

12054

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1782

7194

1.79

105.43

2.3

2.2

131.12

130.49

g/l

0.44

1322

5269

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2119

24302

0.61

105.24

1.5

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

54289

372091

1.34

104.40

13.2

9.5

27.26

26.49

u/l

7.69

52331

359855

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1768

7142

1.78

104.37

1.2

1.3

3.82

3.73

mmol/l

2.24

1652

6708

(3020564) Creatinine [Moles/volume] in Serum or Plasma

54077

370493

1.34

103.47

21.5

14.7

76.20

76.73

umol/l

2.82

54068

370288

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10332

59360

1.29

103.36

1.3

30.34

35.67

iu/ml

1.93

2843

18861

(3043409) Potassium [Moles/volume] in Arterial blood

2135

9160

1.68

101.82

4.6

4.5

3.83

3.88

mmol/l

4.29

1993

8614

(3028026) IgM [Mass/volume] in Serum or Plasma

3908

19275

1.47

101.78

1.8

1.9

1.35

1.31

g/l

0.55

3537

17621

(40768804) Tissue Pathology biopsy report

22179

138975

1.21

100.77

2.2

2.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2199

9610

1.65

97.71

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

105

15.27

96.89

1.5

1.2

424.07

622.05

nmol/l

1.43

105

(3014765) Yersinia sp identified in Stool by Organism specific culture

2210

9707

1.64

96.26

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2213

9732

1.64

95.93

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1397

5393

1.86

95.43

1.4

1.3

24.42

25.85

u/l

0.82

1081

4519

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1737

7170

1.74

95.18

1.4

27.68

31.11

e6/l

0.15

1338

5554

(3044290) Cell count panel - Cerebral spinal fluid

1653

6729

1.77

95.02

1.3

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1735

7180

1.74

94.22

1.4

1.5

3098.43

1801.38

e6/l

0.27

1421

5832

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1690

6959

1.75

93.38

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

8130

45839

1.30

92.76

2.4

2.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3773

18820

1.45

92.42

3.6

3.4

129.35

129.34

g/l

0.01

3676

18399

(3050129) First trimester maternal screen panel - Serum or Plasma

1107

14568

0.53

91.36

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2969

14162

1.52

90.71

1.6

1.8

1.61

1.50

g/l

7.01

2480

12141

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1741

7304

1.72

90.04

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5894

31903

1.35

89.26

3.6

4.0

23.37

25.13

ug/l

0.17

4755

25405

(3007566) Smooth muscle Ab [Titer] in Serum

2071

9160

1.63

87.66

1.2

93.82

126.12

titre

1.66

186

833

(36660697) Celiac disease serology panel - Serum

5145

27344

1.37

87.52

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

1065

3870

1.97

87.05

1.5

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1074

3933

1.96

85.87

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1074

3936

1.96

85.68

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1074

3941

1.96

85.37

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1103

4085

1.94

85.36

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1082

3981

1.95

85.35

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1079

3991

1.94

83.82

1.5

1.4

—

(3024928) Oxygen saturation in Venous blood

1549

6428

1.73

83.25

3.1

3.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

14208

86547

1.22

81.67

1.7

1.6

1.54

1.36

mmol/l

67.88

11750

73436

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

763

10905

0.49

81.62

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1306

5189

1.81

81.36

1.7

—

(3003338) MCHC [Mass/volume]

40728

306181

0.84

80.67

26.7

16.0

331.96

332.74

g/l

55.79

40404

303748

(3016650) Hepatitis A virus Ab [Presence] in Serum

1362

5509

1.78

79.96

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

9567

55976

1.26

79.73

1.3

9.38

11.74

u/ml

2.58

3356

22398

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4822

25744

1.36

79.31

3.0

2.8

192.30

204.73

ng/l

1.05

4343

23368

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

463

1222

2.71

79.10

2.8

2.3

58.45

51.96

umol/l

3.78

377

1012

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1650

7072

1.68

78.82

1.7

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

930

12323

0.53

78.33

1.4

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2071

9419

1.58

78.07

1.9

1.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

455

1215

2.68

76.05

2.6

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1336

5454

1.76

76.00

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1703

7434

1.65

75.83

1.5

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1005

3759

1.92

75.57

2.2

2.0

25.01

26.49

mg/l

0.33

255

1025

(3009214) Lutropin [Units/volume] in Serum or Plasma

2274

10656

1.54

75.17

1.4

10.18

9.79

u/l

0.63

1792

8812

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1128

4410

1.84

74.04

1.3

0.16

0.26

nmol/l

2.42

260

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

696

9924

0.49

73.86

1.8

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1127

4425

1.83

72.97

1.3

1.73

1.18

nmol/l

0.27

1083

4262

(3034770) Mitochondria Ab [Titer] in Serum

1980

9063

1.57

72.58

1.2

795.12

960.68

titre

0.44

266

(3026493) Urate [Moles/volume] in Serum or Plasma

14419

88823

1.20

72.02

2.6

4214.56

4163.85

umol/l

0.05

12107

78004

(3014271) Vancomycin [Susceptibility]

487

1389

2.51

71.44

3.1

2.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4520

24295

1.35

70.79

1.2

111.18

146.60

iu/ml

7.67

1472

9404

(3036180) Methadone [Presence] in Urine

17.68

70.75

3.1

2.4

—

(3017732) Neutrophils [#/volume] in Blood

4400

23596

1.35

69.92

3.8

2.6

4.21

4.10

e9/l

1.86

3174

18671

(3043238) Trisomy 21 risk [Likelihood] in Fetus

689

9668

0.50

69.61

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

895

11580

0.54

69.44

1.3

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3494

18071

1.40

69.42

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

893

11553

0.54

69.26

1.3

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2780

13805

1.45

69.18

4.2

3.9

51.58

47.80

12.51

2735

13667

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

896

11572

0.54

69.08

1.3

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1029

3995

1.85

69.06

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2977

14985

1.43

68.91

3.7

3.4

25.35

25.21

mmol/l

1.43

2891

14524

(3005033) Fetal Nuchal fold Thickness US

669

9437

0.50

68.69

1.3

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

671

9454

0.50

68.64

1.3

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

893

11513

0.55

68.43

1.3

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2176

10313

1.52

68.19

2.7

2.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

547

8196

0.47

67.06

1.3

1.5

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

917

3472

1.89

66.51

1.3

21.60

30.24

nmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4165

38783

0.75

66.46

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3238

16689

1.40

65.55

2.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2561

12649

1.46

65.49

1.6

1.7

—

(3042631) Mycobacterium sp identified in Specimen

1019

4025

1.81

64.74

2.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

817

3012

1.94

64.15

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2390

11707

1.47

63.75

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1199

5029

1.71

62.02

2.8

3.3

1.37

1.45

0.30

903

3903

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4675

25748

1.32

61.57

2.6

2.1

12.18

12.39

nmol/l

0.94

3974

23073

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2225

10848

1.48

60.73

2.1

2.3

3.05

3.06

g/l

0.12

1689

8441

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

660

2305

2.05

60.29

1.6

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

909

3544

1.84

60.24

8.8

7.9

7.24

7.36

mmol/l

0.30

763

2878

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

737

2683

1.97

60.04

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1142

4798

1.71

58.72

1.4

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1330

5826

1.64

58.40

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

383

1078

2.54

57.85

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1010

4123

1.76

57.51

1.6

1.5

—

(3037121) Protein [Mass/volume] in Urine

2229

10997

1.46

57.23

3.0

3.2

0.28

0.33

g/l

1.45

921

4962

(40761511) CBC panel - Blood by Automated count

53039

366535

1.23

56.86

18.5

12.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2324

11572

1.45

56.85

2.1

2.2

7.43

7.34

g/l

1.26

1725

8624

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

973

3945

1.77

56.72

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2320

11560

1.44

56.54

2.1

2.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2016

9786

1.48

56.21

2.2

2.4

0.68

0.89

g/l

2.07

1677

8446

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2313

11541

1.44

55.95

2.1

2.2

3.77

3.84

g/l

0.92

1648

8222

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1239

5399

1.65

55.54

1.5

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

684

2506

1.95

54.76

1.3

1.98

2.10

mmol/l

1.95

635

2320

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1086

4593

1.69

54.53

1.5

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1205

5269

1.64

53.30

3.4

3.1

0.81

0.80

nmol/l

0.29

889

4092

(3008757) Leukocyte morphology finding [Identifier] in Blood

840

3322

1.81

53.22

3.1

3.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

11617

71785

1.19

53.17

2.0

1.9

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

11.01

53.04

1.7

1.3

266.64

195.41

nmol/l

0.53

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1536

7128

1.55

52.94

2.1

1.8

191.97

196.10

pmol/l

0.71

1426

6804

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2167

10793

1.44

52.90

2.1

2.2

9.88

10.30

g/l

4.11

1763

9044

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3889

21320

1.32

52.62

1.3

52.42

48.63

au/ml

0.34

132

891

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4212

23353

1.30

52.49

2.4

2.3

24.98

23.24

au/ml

0.33

200

1453

(3011985) Renin [Units/volume] in Plasma

1029

4348

1.70

51.86

1.5

1.6

59.00

66.36

mu/l

0.58

898

3919

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1842

8932

1.48

51.60

2.1

2.2

37.81

37.75

g/l

0.14

1532

7702

(3041096) Erythrocytes [Presence] in Urine by Automated

14846

93800

1.17

51.52

4.0

3.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

8.90

51.14

2.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

143

232

4.39

51.00

1.2

50.67

46.15

mg/l

0.44

(3013139) Helicobacter pylori Ag [Presence] in Stool

4070

22594

1.30

50.17

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3207

17221

1.34

49.98

9.9

9.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2601

13545

1.38

49.26

1.3

1.2

0.59

0.87

u/ml

0.95

216

1176

(3017354) Segmented neutrophils/100 leukocytes in Blood

770

3041

1.81

49.05

2.8

3.3

57.98

58.72

0.34

479

1954

(3034860) Kappa light chains.free [Mass/volume] in Serum

1899

9400

1.45

47.87

3.3

58.80

66.86

mg/l

0.36

1491

7632

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

729

2859

1.82

47.52

2.8

2.7

—

(4035726)

4938

28280

1.26

47.43

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1118

4943

1.62

47.35

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

802

3250

1.77

46.91

1.6

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

985

4234

1.67

46.60

1.5

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

674

2596

1.86

46.53

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

674

2596

1.86

46.53

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

674

2596

1.86

46.53

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2698

14264

1.36

46.48

1.4

1.5

13.41

14.79

u/ml

0.14

408

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1771

8701

1.46

46.42

2.1

2.2

0.02

0.03

g/l

0.75

1576

7978

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1841

9122

1.45

46.16

3.2

4.69

4.09

ratio

0.07

160

705

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1886

9396

1.44

45.94

3.3

38.56

43.49

mg/l

0.64

1476

7639

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

352

5380

0.46

45.68

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

825

3404

1.73

45.35

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

960

4134

1.66

45.12

6.6

6.1

11.34

11.46

mg/l

0.35

869

3806

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2177

11176

1.40

44.85

1.6

249.51

286.30

titre

0.26

471

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

356

1093

2.32

44.79

1.4

14.06

15.02

pmol/l

2.22

273

944

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

674

2628

1.83

44.79

1.6

2.1

19.02

18.50

nmol/l

0.70

612

2513

(3019977) pH of Arterial blood

472

1631

2.07

44.52

3.2

2.3

7.42

0.08

166

566

(3021367) Citalopram [Moles/volume] in Serum or Plasma

12.02

44.27

1.5

1.4

147.57

122.58

nmol/l

0.43

(3016018) Differential panel - Cerebral spinal fluid

848

3555

1.71

44.05

1.4

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

530

1924

1.97

43.68

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1640

8033

1.46

43.66

2.1

2.3

0.00

g/l

0.02

1450

7336

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2585

13719

1.36

43.42

1.1

8.66

9.31

u/ml

0.03

212

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

520

1891

1.96

42.66

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

8.42

42.64

1.1

—

mmol/l

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

420

1416

2.12

42.26

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

389

1272

2.18

42.25

1.7

2.03

1.96

umol/l

0.84

360

1197

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

503

1815

1.98

42.19

1.0

39.34

42.36

ng/l

0.77

358

1262

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

420

1417

2.12

42.19

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1691

8399

1.44

41.86

1.8

1.9

15.33

18.82

iu/l

0.13

559

3148

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

928

4043

1.64

41.73

1.3

1.4

321.89

300.80

pmol/l

0.69

702

3161

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

498

1803

1.97

41.39

1.0

281.97

344.56

ng/l

2.02

364

1274

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

500

1814

1.97

41.31

1.0

786.35

736.51

ng/l

1.49

347

1241

(3023410) Appearance of Cerebral spinal fluid

786

3286

1.71

41.28

1.4

1.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

475

1695

2.00

41.12

1.3

1.2

254.10

328.84

u/l

0.98

443

1586

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

21.36

41.04

3.3

2.5

339.62

370.15

nmol/l

—

(3023419) Bacteria identified in Sputum by Culture

867

3730

1.66

40.94

2.5

2.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

375

1226

2.18

40.77

1.3

1.4

73.74

72.79

0.69

351

1172

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1603

7934

1.45

40.44

2.2

2.3

0.00

g/l

0.00

1443

7318

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4743

27538

1.24

40.12

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1433

6951

1.48

40.10

1.5

1.6

—

(3017509) Phencyclidine [Presence] in Urine

166

360

3.29

39.99

2.4

1.6

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

9.79

39.97

1.8

1.4

196.95

411.85

nmol/l

0.92

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

156

325

3.42

39.95

3.4

3.1

39.46

43.46

umol/l

1.26

139

270

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1952

10034

1.40

39.89

1.9

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2018

10432

1.39

39.88

3.1

0.36

0.34

u/ml

0.93

1166

5891

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

367

1201

2.18

39.82

1.3

1.4

635.07

698.81

mu/l

0.21

343

1147

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

368

1210

2.17

39.47

1.6

1.7

29.25

29.17

umol/l

0.05

358

1163

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

721

2982

1.73

39.37

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

1444

7043

1.47

39.30

3.4

3.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1379

6671

1.48

39.12

1.4

1.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

1141

5320

1.54

38.57

3.2

63.50

64.96

1.40

1131

5300

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1786

9096

1.41

38.51

1.2

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

440

1568

2.00

38.28

1.6

1.5

22.24

25.80

umol/l

1.66

415

1493

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

791

3382

1.67

38.27

1.2

58.74

65.02

u/l

1.04

520

2312

(3044242) Glucose [Moles/volume] in Arterial blood

395

1358

2.08

37.86

2.4

1.8

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

931

4167

1.60

37.59

1.9

1.8

2776.36

4285.26

titre

0.71

175

(3019897) Erythrocyte distribution width [Ratio] by Automated count

409

5562

0.52

37.50

4.7

2.4

13.32

13.14

2.89

401

5493

(3032057) Clostridioides difficile [Presence] in Stool

223

603

2.64

36.71

1.8

1.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

222

599

2.64

36.70

1.1

0.82

3.03

umol/24h

0.48

312

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1987

10393

1.37

36.56

2.0

1.7

40.18

41.29

nmol/l

1.18

1921

10169

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

851

3763

1.62

36.14

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

441

1606

1.96

36.13

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

443

1620

1.95

35.87

1.6

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1310

6402

1.47

35.33

1.2

94.44

133.73

titre

0.71

134

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1953

10275

1.36

34.64

1.7

0.23

g/l

0.27

1845

9750

(3017569) Oxygen content in Arterial blood

377

1320

2.04

34.48

2.5

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2813

15615

1.30

34.40

2.6

2.3

5543.17

6003.41

u/l

0.29

890

6485

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

805

3562

1.62

34.12

1.1

40.46

26.99

au/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2153

11557

1.34

33.49

1.3

1.4

—

(40768443) Skin Pathology biopsy report

2630

14523

1.30

33.45

1.2

—

(4146454)

742

3234

1.64

33.42

2.6

2.8

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

789

3493

1.61

33.38

1.1

37.03

72.52

au/ml

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

599

2471

1.73

33.11

1.1

292.98

409.96

mg/l

0.49

524

2232

(3006922) Hepatitis E virus Ab [Presence] in Serum

576

2351

1.75

33.05

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

257

784

2.34

32.98

1.4

1.2

135.44

125.21

nmol/l

0.42

178

593

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

676

2886

1.67

32.98

3.9

3.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

456

1737

1.87

32.77

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

538

6509

0.58

32.68

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1220

5974

1.46

32.60

3.1

3.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1989

10596

1.35

32.55

1.6

1.7

1.20

1.17

g/l

2.69

1881

10091

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1740

9081

1.37

32.47

1.4

1.5

16.95

13.59

iu/ml

0.40

215

(3037756) Immunofixation for Serum or Plasma

1260

6220

1.45

32.28

1.6

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

475

1851

1.83

31.81

1.6

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

533

2153

1.77

31.71

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3076

17448

1.27

31.64

3.1

2.6

0.26

0.28

e6/l

0.55

2987

16953

(4024509)

669

2880

1.66

31.64

1.8

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

420

1577

1.90

31.55

1.8

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

534

2164

1.76

31.43

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

419

1576

1.90

31.32

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

419

1576

1.90

31.32

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

419

1576

1.90

31.32

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1245

6170

1.44

31.26

3.0

3.4

586.36

843.25

u/ml

0.46

1108

5611

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

443

1707

1.85

30.76

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1786

9443

1.36

30.71

1.3

32.59

36.98

u/ml

0.27

573

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

515

2082

1.77

30.58

1.9

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2558

14267

1.29

30.13

1.8

2.0

39.44

39.36

u/l

0.07

2239

12777

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1034

4980

1.49

30.07

1.6

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2928

16624

1.27

29.87

1.1

227.15

202.00

titre

0.12

444

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

213

625

2.43

29.82

1.2

—

(3049717) Cytology report of Urine Cyto stain

2155

11779

1.31

29.54

2.4

2.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

3790

22177

1.23

29.53

1.3

249.35

241.00

u/ml

0.10

3473

20595

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

709

3154

1.61

29.48

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3154

18097

1.25

29.39

1.4

1.3

25.00

27.43

iu/l

3.94

2603

15728

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.80

28.58

1.7

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1952

10583

1.32

28.36

1.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

392

1492

1.87

28.33

1.5

1.6

2.86

8.70

nmol/l

0.88

321

1249

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

789

3638

1.55

28.18

1.9

28.16

23.86

ug/l

0.54

772

3565

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

50139

348438

1.13

27.95

5.3

4.5

2.72

2.79

mmol/l

64.59

45425

324407

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

482

1965

1.75

27.87

1.6

6.00

6.44

u/l

0.21

230

965

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7466

60273

0.86

27.86

3.0

2.9

0.69

0.77

ug/l

6.31

4992

38548

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

284

975

2.08

27.50

1.3

1.2

20.09

20.94

0.06

177

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

333

1213

1.96

27.43

2.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

923

4428

1.49

27.41

2.5

2.7

135.64

854.63

u/ml

1.85

895

4201

(3024980) IgG subclass 4 [Mass/volume] in Serum

1098

5451

1.44

27.37

1.5

1.6

0.69

0.76

g/l

1.22

807

4118

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

333

1214

1.96

27.36

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

336

1230

1.95

27.29

2.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10584

83370

0.88

27.24

4.2

4.1

21.67

22.00

1.22

4626

39076

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

775

3587

1.54

27.23

3.1

3.3

6.31

7.36

nmol/l

0.25

746

3481

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1655

8814

1.35

27.17

3.1

3.4

1.57

1.51

mg/l

1.71

1493

8144

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

273

930

2.09

26.99

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3041

17548

1.25

26.92

3.5

3.1

65.98

47.43

u/ml

1.01

2926

16953

(3002256) Pathology report gross observation

7109

44338

1.16

26.86

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2355

13195

1.28

26.75

1.7

1.6

3.87

3.44

mg/l

1.34

1873

8995

(3044927) Protein electrophoresis panel - Urine

645

2876

1.60

26.63

1.3

1.2

—

(3051651) Icteric interference index of Serum or Plasma

462

1887

1.75

26.57

3.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

201

608

2.36

26.42

1.4

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

263

896

2.09

26.02

3.5

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

263

896

2.09

26.02

3.4

2.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1489

7863

1.36

25.85

1.2

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

151

403

2.67

25.68

1.1

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

743

3456

1.54

25.57

1.3

1.4

6.66

6.77

g/l

0.31

503

2404

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

440

1794

1.75

25.49

1.4

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

266

919

2.06

25.39

1.3

1.4

—

(3022621) pH of Urine by Test strip

3694

21888

1.21

25.35

3.5

2.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

303

1100

1.96

25.25

1.8

2.4

1.03

1.11

ug/l

0.30

283

1030

(4062490)

742

3461

1.53

25.22

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

740

3453

1.53

25.11

1.3

1.4

0.38

0.41

g/l

1.44

508

2409

(3028192) IgG subclass 2 [Mass/volume] in Serum

740

3455

1.53

25.04

1.3

1.4

2.90

2.99

g/l

0.63

503

2402

(3036489) Thrombin time

2294

12921

1.27

24.98

1.9

2.1

21.32

21.46

0.43

1981

11183

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

817

3898

1.50

24.97

2.1

2.2

32.61

32.63

0.04

809

3869

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3511

20772

1.21

24.46

2.0

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

520

2250

1.65

24.27

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

176

522

2.40

24.20

2.2

2.4

—

(3047181) Lactate [Moles/volume] in Blood

1854

10207

1.30

24.13

6.5

5.6

1.34

1.29

mmol/l

1.04

1668

8994

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

358

1396

1.83

24.08

3.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

913

4493

1.45

23.91

1.1

1.54

1.50

g/l

2.17

800

4094

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

520

2268

1.64

23.54

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

398

1615

1.76

23.49

1.2

1.1

85.47

85.75

u/l

0.02

323

1280

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

400

1626

1.76

23.46

1.3

58.23

64.03

0.54

192

(3051611) Lipemic interference index of Serum or Plasma

709

3328

1.52

23.45

3.6

3.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

398

1616

1.76

23.44

1.1

23.44

25.27

u/l

0.17

306

1237

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1612

8755

1.32

23.18

1.3

7.61

8.41

u/ml

0.20

240

1378

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1482

13817

0.76

23.11

1.8

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

413

1706

1.73

22.92

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

252

3399

0.53

22.72

1.5

1.6

8.08

7.57

mmol/l

2.46

173

2008

(3018851) Theophylline [Moles/volume] in Serum or Plasma

100

227

3.14

22.65

1.6

1.8

51.54

44.37

umol/l

1.14

100

227

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

222

3101

0.51

22.39

1.4

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

47321

328712

1.11

22.37

4.3

3.7

1.42

1.28

mmol/l

232.48

42522

305129

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

487

2118

1.64

22.33

3.2

3.3

112.36

132.23

nmol/l

0.81

469

2087

(40757494) Bilirubin.total [Moles/volume] in Blood

396

1633

1.73

22.14

2.0

2.1

19.22

32.39

umol/l

1.20

153

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

496

2174

1.63

22.06

1.2

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

993

5047

1.41

21.83

2.1

5.71

7.28

titre

0.28

144

(3013676) Sertraline [Moles/volume] in Serum or Plasma

8.07

21.69

1.3

156.81

200.42

nmol/l

0.44

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1846

10324

1.28

21.32

2.5

2.6

3.65

3.62

g/l

0.40

1733

9859

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1576

8642

1.31

21.17

1.3

7.37

6.34

u/ml

0.18

157

907

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1317

7053

1.34

20.92

1.2

44.43

43.25

u/ml

0.08

123

702

(3000093) Morphology [Interpretation] in Blood Narrative

644

3039

1.51

20.85

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3071

18218

1.21

20.78

1.3

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

625

2934

1.52

20.74

3.9

3.7

43.80

48.93

u/ml

0.26

616

2900

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

434

1875

1.65

20.48

1.1

2.00

5.62

nmol/l

1.92

375

(3004451) EKG impression Narrative

352

1437

1.75

20.43

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4375

26834

1.17

20.26

2.8

2.6

67.45

67.05

ml/min/173m2

0.25

1827

10476

(3028433) Virus identified in Specimen by Culture

276

1049

1.88

20.22

1.2

—

(3045414) Leukocytes [Presence] in Urine

2579

15103

1.22

19.87

1.9

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

819

4094

1.43

19.82

1.4

1.3

—

(40768793) Breast Pathology biopsy report

1329

7190

1.32

19.70

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

606

2864

1.51

19.52

1.4

1.3

1.57

1.41

nmol/l

2.82

539

2598

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1955

11148

1.26

19.24

3.3

3.5

960.29

1942.91

u/ml

0.78

1675

9551

(40761539) Cells [Type] in Urine sediment by Light microscopy

220

788

1.99

19.20

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1268

6845

1.32

19.11

5.0

5.8

669.60

1768.41

iu/ml

0.96

151

1043

(3045716) Anion gap in Serum or Plasma

337

1390

1.73

18.92

2.4

8.98

9.22

mmol/l

0.54

256

1009

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

115

314

2.61

18.87

2.3

2.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

474

2141

1.58

18.73

3.1

3.3

31.49

26.97

mu/l

1.39

435

2016

(3010015) Selenium [Moles/volume] in Serum or Plasma

248

2.81

18.55

2.0

1.29

1.33

umol/l

0.48

221

(3001019) Free T4 and TSH panel - Serum or Plasma

2382

20485

0.82

18.54

1.8

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

720

3560

1.44

18.52

1.1

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

197

688

2.04

18.45

1.5

1.6

0.39

0.40

ug/l

0.08

120

463

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1456

8058

1.29

18.30

1.3

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

425

1883

1.61

18.21

1.2

25.76

24.56

u/l

0.17

356

1640

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

520

2416

1.54

18.17

2.5

794.32

722.77

e6/l

0.57

222

985

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

435

1941

1.60

18.11

1.2

95.87

90.45

u/l

0.46

375

1713

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

209

752

1.98

18.05

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1295

7070

1.31

18.03

1.2

2.90

5.92

u/ml

1.50

549

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

367

1571

1.67

18.02

1.1

5.77

10.30

u/ml

2.74

271

(3024869) Neuronal Ab [Presence] in Serum

163

534

2.17

17.99

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

591

2829

1.49

17.95

1.2

36.46

44.19

mg/l

2.97

482

2371

(3001186) Copper [Moles/volume] in Serum or Plasma

214

779

1.96

17.89

1.3

17.19

16.80

umol/l

0.52

186

697

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2261

13208

1.23

17.86

5.7

4.8

1.83

1.67

6.79

2126

12384

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1282

7002

1.31

17.80

1.2

12.44

15.10

u/ml

0.10

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

252

974

1.84

17.61

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

4277

26477

1.16

17.53

2.2

2.0

—

(1002224) Polysomnography panel

2519

14911

1.21

17.44

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

408

1810

1.61

17.42

1.9

1.7

2.45

2.33

u/field

0.10

304

1294

(4034850)

1876

10773

1.25

17.39

12.2

9.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

49140

343015

1.10

17.23

4.8

4.1

4.61

4.69

mmol/l

52.72

44724

321293

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1067

5719

1.33

16.95

1.5

1.4

0.36

0.42

nmol/l

1.13

809

4532

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

978

5175

1.35

16.93

2.4

2.8

1593.04

6343.44

u/ml

0.96

285

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

568

2731

1.48

16.92

1.1

251.99

269.13

mg/l

0.70

486

2405

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

538

2559

1.50

16.89

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

986

5226

1.35

16.88

1.5

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1947

11292

1.23

16.50

1.2

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

121

364

2.37

16.32

2.2

2.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

301

1256

1.71

16.30

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

417

1893

1.57

16.21

1.4

1.2

4.73

5.08

umol/l

1.09

383

1744

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1604

9126

1.26

16.16

1.9

2.1

10.88

10.85

mg/l

0.05

1467

8559

(3021788) Differential panel - Synovial fluid

1095

5937

1.32

16.08

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

215

814

1.88

16.07

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

416

1901

1.56

15.74

1.4

6.38

5.80

u/l

0.36

332

1609

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

463

2168

1.52

15.70

1.5

23.90

25.01

u/ml

0.16

433

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

711

3625

1.40

15.52

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

213

815

1.86

15.44

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

245

2.64

15.44

1.3

1.4

15.62

12.23

pmol/l

0.24

204

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

211

805

1.87

15.43

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

415

1905

1.55

15.40

1.1

1.05

1.07

u/l

0.25

167

884

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1268

7053

1.28

15.40

1.2

1.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.63

15.05

1.5

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

212

817

1.85

15.05

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

322

1399

1.64

15.04

7.2

10.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1728

10000

1.24

14.98

2.3

2.6

191.65

185.27

1.99

1610

9486

(3010503) CD19 cells [#/volume] in Blood

430

2003

1.53

14.96

2.7

2.5

0.16

0.35

e9/l

2.24

414

1955

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

461

2184

1.51

14.83

1.4

12.00

12.84

u/l

1.89

441

2113

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

430

2010

1.53

14.74

2.1

2.0

99.45

98.22

0.29

396

1875

(3006442) Creatine [Moles/volume] in Serum or Plasma

490

2357

1.48

14.65

1.8

1.5

62.28

70.92

umol/l

2.08

190

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

193

728

1.89

14.65

1.3

1.2

431.58

295.17

pmol/l

0.83

129

549

(3045424) Erythrocytes [Presence] in Urine

1050

5737

1.31

14.63

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1378

7795

1.26

14.62

1.7

1.6

13885.44

13180.32

e6/l

0.18

952

5731

(3038026) Centromere Ab [Units/volume] in Serum

540

2649

1.45

14.61

1.2

45.82

51.30

u/ml

0.11

123

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

405

1873

1.54

14.58

1.3

168.62

492.35

titre

2.46

136

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

163

581

2.00

14.57

2.3

2.5

6.85

7.58

mmol/l

1.57

101

344

(3007930) Methemoglobin/Hemoglobin.total in Blood

2188

13005

1.20

14.55

5.9

4.9

0.88

0.90

1.54

2055

12194

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9199

60300

1.10

14.50

1.7

—

(4015189)

204

788

1.84

14.40

2.7

2.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

384

1762

1.55

14.32

1.6

1.30

1.25

nmol/l

0.42

290

1404

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

540

2661

1.45

14.29

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

162

581

1.99

14.25

1.3

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

325

2.34

14.20

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

48708

340600

1.09

13.84

4.8

4.1

1.42

1.46

mmol/l

88.29

44116

317707

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

392

1823

1.53

13.79

1.3

47.50

80.00

titre

1.28

163

(44806118)

683

3539

1.38

13.62

1.5

—

(44790049)

683

3540

1.38

13.59

1.5

—

(44790048)

683

3541

1.38

13.57

1.5

—

(44790047)

683

3541

1.38

13.57

1.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

150

533

2.00

13.56

1.2

1.4

76.52

251.53

ng/l

0.62

364

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

548

2738

1.43

13.49

1.2

131.76

190.28

titre

1.21

457

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

522

2586

1.44

13.46

1.2

84.41

65.04

u/ml

0.86

106

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1183

6643

1.27

13.39

1.2

1.3

275.68

264.78

u/ml

0.65

737

4382

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

149

532

1.99

13.30

2.3

2.6

29.64

60.56

mg/l

1.51

(40768806) Pleura Pathology biopsy report

600

3055

1.40

13.29

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

522

2593

1.44

13.28

1.2

46.20

46.25

u/ml

0.00

180

(3028308) Erythrocytes [#/volume] in Pleural fluid

630

3236

1.39

13.26

1.4

1.5

54148.77

55698.15

e6/l

0.05

391

1931

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

545

2732

1.42

13.19

1.2

65.00

194.07

titre

2.86

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

488

2398

1.45

13.15

1.5

1.4

12.27

12.10

umol/l

0.19

450

2287

(3023199) Leukocytes [#/volume] in Pleural fluid

686

3579

1.37

13.13

1.5

4944.08

2925.53

e6/l

0.74

511

2589

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

501

2479

1.44

13.02

1.2

6.53

8.93

u/ml

0.26

160

(3044941) Cell count panel - Synovial fluid

916

4996

1.31

13.00

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

188

735

1.82

12.84

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

118

391

2.15

12.83

2.6

2.4

0.68

0.57

u/field

0.59

118

391

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

524

2628

1.42

12.67

2.1

1.9

2.37

2.28

u/field

0.12

272

1126

(3022493) Free Hemoglobin [Mass/volume] in Plasma

309

1390

1.58

12.63

4.0

5.0

1383.93

2616.85

mg/l

0.58

213

995

(21494815) CD4 cells/100 lymphocytes in Specimen

575

2934

1.40

12.61

2.3

2.1

43.20

40.68

0.73

380

(3003434) Protein [Mass/volume] in Pleural fluid

748

3983

1.34

12.57

1.4

1.5

34.15

32.80

g/l

2.17

677

3581

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

583

2986

1.39

12.51

1.3

—

(3011412) CD3 cells [#/volume] in Blood

631

3275

1.37

12.50

2.4

1.24

1.15

e9/l

1.37

349

1968

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

292

1301

1.60

12.43

1.1

1462.93

424.82

ng/l

0.58

315

(3010838) Calcium [Moles/time] in 24 hour Urine

340

1571

1.54

12.38

1.6

5.66

5.58

mmol/24h

0.03

127

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1844

10957

1.20

12.36

2.1

2.3

92.63

92.12

0.39

1694

10200

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1169

6624

1.26

12.31

1.8

2.2

0.89

0.84

nmol/l

1.86

942

5587

(3035320) C reactive protein [Mass/volume] in Body fluid

483

2402

1.43

12.26

3.0

2.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1262

7221

1.25

12.22

1.3

1.4

18.35

19.72

u/ml

0.13

142

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

140

505

1.97

12.20

1.1

1.2

—

(4027681)

446

2188

1.45

12.17

1.3

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

350

1643

1.52

11.88

1.1

3.88

4.02

iu/ml

0.08

126

(3012441) Differential panel - Pleural fluid

592

3071

1.38

11.80

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

259

1138

1.62

11.71

1.2

113.25

110.84

0.70

227

1021

(40768800) Prostate Pathology biopsy report

659

6239

0.75

11.69

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

106

350

2.16

11.68

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

165

640

1.84

11.61

1.5

1.4

—

(40768441) Liver Pathology biopsy report

473

2370

1.42

11.56

1.4

—

(3003694) ABO and Rh group [Type] in Blood

13615

102419

0.93

11.55

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1562

9202

1.21

11.49

1.2

—

(3000012) Reticulocyte production index

358

1704

1.50

11.41

1.4

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

448

2234

1.43

11.25

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

491

2496

1.40

11.08

1.2

1.3

1.06

1.29

u/ml

0.28

230

1100

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

235

1024

1.64

11.01

3.2

3.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

146

555

1.87

10.97

1.8

1.9

1.18

mmol/l

0.00

140

530

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

889

4957

1.28

10.76

1.3

31.09

34.83

u/l

0.50

756

4335

(3000492) Spirometry study

5264

34048

1.11

10.67

1.5

1.4

—

(40762365) Oxygen content in Arterial blood by calculation

134

500

1.91

10.66

3.0

3.1

14.62

14.82

ml/dl

0.34

124

464

(3006270) Folate [Moles/volume] in Blood

529

2752

1.37

10.43

1.2

1.1

359.95

370.11

nmol/l

0.51

453

2322

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

120

435

1.96

10.39

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

285

1322

1.54

10.30

2.7

2.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

462

2357

1.40

10.26

2.5

559.63

526.98

e6/l

0.59

381

1977

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1251

7295

1.22

10.24

1.4

1.5

—

(3033799) Differential panel - Peritoneal fluid

209

904

1.65

10.13

2.2

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

320

2.11

10.03

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

311

2.13

10.00

1.1

1.74

2.89

umol/24h

0.49

311

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

517

2699

1.37

10.00

1.3

579.03

473.07

u/l

0.45

479

2562

(3019420) Tryptase [Mass/volume] in Serum or Plasma

375

1852

1.44

9.99

1.5

8.44

7.87

ug/l

0.17

339

1680

(3003129) Base excess in Capillary blood by calculation

182

763

1.70

9.93

1.9

1.6

0.99

0.42

mmol/l

1.13

171

720

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

117

429

1.94

9.84

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

161

655

1.75

9.78

1.4

1.3

72.45

76.79

mu/l

0.08

106

507

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13979

104559

0.94

9.73

4.8

4.7

3.29

3.20

ug/l

0.08

12185

94403

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1464

8715

1.20

9.72

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

896

5069

1.26

9.68

4.0

3.5

50.18

35.33

u/ml

1.19

858

4890

(3039000) Anion gap in Blood

1230

7211

1.22

9.58

7.9

6.5

11.19

11.25

mmol/l

0.25

1127

6487

(3018572) Chloride [Moles/volume] in Blood

1230

7212

1.22

9.57

7.9

6.5

104.61

105.19

mmol/l

3.35

1127

6489

(3019832) Treponema pallidum Ab [Presence] in Serum

5251

40801

0.91

9.55

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

275

1292

1.52

9.43

1.1

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

264

1234

1.52

9.28

1.2

0.32

0.30

g/l

2.88

210

977

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

123

469

1.87

9.24

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1321

7831

1.20

9.20

1.4

175.39

118.79

pmol/l

1.94

1290

7631

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

297

1427

1.48

9.16

1.8

1.9

—

(3006576) Bicarbonate [Moles/volume] in Blood

241

1111

1.55

9.03

5.4

6.3

25.08

25.05

mmol/l

0.04

221

1008

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

174

743

1.67

8.93

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

126

490

1.83

8.92

1.1

—

(3020491) Glucose [Moles/volume] in Blood

488

2575

1.35

8.88

1.9

1.7

7.03

6.67

mmol/l

1.56

356

1909

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

262

1236

1.51

8.85

2.7

2.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

506

2688

1.34

8.82

2.0

1.30

0.97

g/24h

0.39

152

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.95

8.65

1.0

1.1

221.75

203.31

pmol/l

0.09

(3036782) Glucose [Moles/volume] in Pleural fluid

527

2828

1.33

8.59

1.3

6.19

6.31

mmol/l

0.46

472

2630

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

+∞

8.18

3.9

0.0

299.89

—

umol/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

276

1339

1.47

8.17

1.1

—

(40757373) Influenza virus identified in Isolate

146

612

1.70

8.07

1.6

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

179

2.35

8.06

1.1

1.0

—

(44813793)

468

2495

1.34

8.02

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

629

5678

0.79

7.91

1.4

1.3

3.05

3.56

ug/l

1.48

536

5116

(3001556) Androgen free Index in Serum or Plasma

371

1.90

7.91

1.4

1.2

—

(3045788) Cell count panel - Pleural fluid

511

2765

1.32

7.91

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1134

6728

1.20

7.90

1.4

1.5

110.14

111.29

u/ml

0.10

265

1544

(3052592) Norovirus Ag [Presence] in Stool

148

628

1.68

7.84

1.4

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

113

444

1.81

7.81

1.2

1.4

44.06

52.99

1.05

215

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

333

1.95

7.80

2.1

2.6

0.78

1.23

mmol/l

1.77

237

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

233

1104

1.50

7.78

1.7

40900.15

21169.16

u/ml

0.21

137

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

826

0.46

7.75

1.1

1.2

—

(3012565) Volume of 24 hour Urine

331

1679

1.40

7.74

2.0

2.2

1990.55

1980.17

0.05

289

1507

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

180

807

1.59

7.69

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

229

1084

1.50

7.68

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

8838

59279

1.07

7.56

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

1243

7468

1.19

7.56

2.2

2.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

191

873

1.56

7.53

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

168

746

1.60

7.48

1.8

1.3

13.09

13.55

g/l

0.25

120

573

(3027974) Hepatitis B virus e Ag [Presence] in Serum

199

2.22

7.48

1.3

1.4

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

160

2.36

7.35

1.7

0.67

0.73

umol/l

0.39

122

(3051339) Copper [Moles/volume] in Blood

156

2.37

7.32

1.1

1.3

17.07

16.49

umol/l

0.42

133

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

244

1186

1.47

7.22

1.1

113.87

108.60

1.12

218

1077

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

236

1140

1.47

7.21

1.1

97.16

90.88

1.42

119

534

(3042111) Morphology [Interpretation] in Bone marrow Narrative

858

5004

1.22

7.17

1.5

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

298

1507

1.41

7.14

2.8

3.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

932

0.51

7.08

3.1

3.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

167

1829

0.65

7.07

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

931

0.51

7.05

6.2

6.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

697

3984

1.25

7.04

1.2

1.1

2.09

1.93

iu/ml

0.07

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

428

2300

1.33

7.01

2.6

2.5

0.23

e9/l

0.12

374

1981

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

201

945

1.51

7.01

2.3

1.8

4444.89

12688.06

e6/l

2.17

124

488

(4281824)

608

3424

1.27

6.99

1.2

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

122

509

1.71

6.94

1.1

1.88

7.66

pmol/l

0.90

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

268

1.99

6.93

1.5

1.6

2.19

1.74

mg/l

0.31

163

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

216

1034

1.49

6.92

1.4

59.04

62.68

0.78

183

838

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

423

2275

1.33

6.90

1.2

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

235

1145

1.46

6.90

1.3

1.2

1.19

0.48

g/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

568

3178

1.27

6.89

2.1

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

304

1554

1.39

6.86

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

239

1171

1.45

6.82

1.1

93.72

90.14

1.01

116

549

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

198

2.16

6.81

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

120

502

1.70

6.77

1.4

1.8

79.89

50.57

pmol/l

0.36

421

(1617658) Protocol used for examination of sentinel lymph nodes

433

2344

1.32

6.76

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1619

10029

1.15

6.75

1.4

1.3

—

(40759632) Porphyrins [Mass/mass] in Stool

4.65

6.69

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

214

2.10

6.67

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1294

7890

1.17

6.65

2.2

2.4

117.98

110.81

ug/min

0.20

730

4761

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

3.36

6.53

1.3

34.27

63.41

e6/l

0.55

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

318

1656

1.37

6.45

1.8

1.9

152.06

140.75

1.42

303

1551

(40763480) Human metapneumovirus Ag [Presence] in Specimen

144

2.32

6.37

1.3

1.4

—

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

5.78

6.34

1.1

86.48

29.97

umol/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

917

5455

1.20

6.32

1.1

11.91

11.41

au/ml

0.06

370

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.87

6.32

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

186

882

1.50

6.29

1.4

3.23

2.61

0.46

166

728

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

229

2.02

6.28

1.1

7.88

10.35

u/l

0.73

229

(3013945) Hepatitis B virus e Ab [Presence] in Serum

196

2.11

6.25

1.3

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

170

795

1.52

6.15

1.4

25.27

21.20

1.07

155

717

(3035880) pH of Pleural fluid

310

1624

1.36

6.09

1.3

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

263

1.92

5.99

1.5

1.6

0.60

0.94

mg/l

0.76

166

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

263

1.92

5.99

1.5

1.6

2.13

1.96

mg/l

0.07

149

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

263

1.92

5.99

1.5

1.6

1.98

2.04

mg/l

0.03

162

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

263

1.92

5.99

1.5

1.6

2.50

2.24

mg/l

0.17

169

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

263

1.92

5.99

1.5

1.6

1.57

2.36

mg/l

0.84

183

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

263

1.92

5.99

1.5

1.6

2.17

2.75

mg/l

0.38

176

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

263

1.92

5.99

1.5

1.6

2.04

1.84

mg/l

0.13

179

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

263

1.92

5.99

1.5

1.6

4.18

3.86

mg/l

0.14

159

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

263

1.92

5.99

1.5

1.6

1.27

1.36

mg/l

0.05

149

(3023487) Leukocytes [#/volume] in Peritoneal fluid

217

1075

1.44

5.92

2.4

1.9

3566.59

3354.84

e6/l

0.03

156

720

(3002331) Protein [Mass/volume] in Peritoneal fluid

145

663

1.56

5.82

1.5

1.3

36.42

35.14

g/l

0.03

105

519

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.68

5.81

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

907

5438

1.19

5.77

1.1

11344.36

695.57

iu/ml

0.51

211

1203

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

184

2.09

5.73

1.1

1.11

1.19

u/field

0.35

126

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.65

5.69

1.3

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1732

10914

1.13

5.67

1.7

1.6

1.85

7.06

iu/ml

1.37

352

2298

(3002385) Erythrocyte distribution width [Ratio]

42058

295094

1.04

5.59

24.2

15.3

13.79

13.62

83.21

41243

288952

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

342

1.77

5.57

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

732

4319

1.21

5.56

1.2

63.29

49.95

u/ml

0.63

277

(3017704) Immunofixation for Urine

312

1661

1.34

5.56

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

550

3152

1.24

5.54

1.5

30.28

31.24

0.23

320

2002

(3013466) aPTT in Blood by Coagulation assay

207

1.99

5.47

1.0

1.1

35.91

37.23

0.83

175

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

154

726

1.51

5.42

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

142

2.21

5.36

1.5

0.13

0.21

u/l

0.23

(3030313) Adrenal Ab [Titer] in Serum

331

1.76

5.34

1.1

—

(3016228) CD19 cells/100 cells in Blood

258

1344

1.37

5.32

2.2

2.0

7.85

8.61

0.59

249

1314

(3029075) Extractable nuclear Ab panel - Serum

198

986

1.43

5.30

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1610

10146

1.13

5.30

1.1

3.02

5.55

u/ml

3.58

148

1410

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

10117

68845

1.05

5.27

1.7

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

207

1044

1.41

5.18

2.1

1.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

351

1.72

5.14

1.1

—

(3016750) Collection duration of Urine

348

1906

1.30

5.12

2.0

2.2

512.24

498.32

min

1.53

241

1434

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

358

1.71

5.06

1.1

—

(3008898) HLA-B27 [Presence]

1961

12542

1.12

5.05

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

139

654

1.51

4.98

5.5

6.2

65.94

71.06

1.26

104

522

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

243

2321

0.74

4.90

1.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

132

617

1.52

4.89

2.0

2.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

387

2164

1.27

4.88

1.3

14.65

13.83

u/l

0.23

355

1998

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

134

2.18

4.88

1.1

665.58

334.34

u/l

0.48

115

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

110

494

1.59

4.85

4.8

5.1

54.63

44.61

ug/min

0.86

388

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

434

2463

1.26

4.84

1.9

1.8

3.61

3.78

mg/l

0.40

400

2358

(21494814) CD8 cells/100 lymphocytes in Specimen

250

1318

1.35

4.82

2.1

2.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

615

5257

0.83

4.81

1.3

7.57

7.01

mmol/l

3.88

458

3754

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

697

4156

1.20

4.81

1.5

1.6

56.68

56.93

0.05

412

2677

(3010144) Erythrocytes [#/volume] in Synovial fluid

528

3065

1.23

4.80

1.4

100067.57

110248.57

e6/l

0.16

357

2120

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

109

490

1.58

4.79

1.3

0.22

0.28

nmol/l

1.19

340

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

114

518

1.57

4.79

1.1

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

222

1155

1.37

4.68

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.90

4.64

1.0

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

111

1202

0.66

4.63

2.7

3.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.47

4.63

1.1

1.0

16.80

15.15

umol/l

—

(1175426) CD3 cells/100 lymphocytes in Blood

458

2632

1.24

4.59

2.0

2.1

74.66

72.63

2.52

436

2530

(3049233) Organic acids panel - Urine

3.56

4.59

1.4

1.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

206

1.90

4.59

1.3

1.6

7.19

14.50

3.39

148

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

257

2409

0.76

4.57

1.3

1.44

1.47

g/l

0.15

129

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

253

1.80

4.53

2.7

2.1

54.59

59.68

0.44

158

(3048879) Bone marrow aspiration report

175

880

1.42

4.52

1.7

1.8

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

307

1687

1.30

4.47

2.1

2.3

199.96

203.48

u/l

0.31

307

1673

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

311

1712

1.29

4.47

1.1

1.2

15.12

12.33

u/ml

0.14

166

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

426

2437

1.25

4.47

2.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

421

1.61

4.46

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

122

573

1.52

4.46

3.8

4.9

45.95

58.79

u/l

0.64

213

(3028679) Herpes simplex virus Ab [Presence] in Serum

350

1964

1.27

4.34

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

190

1.91

4.34

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

458

2653

1.23

4.30

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

834

5102

1.17

4.29

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

246

2294

0.76

4.25

1.3

1.4

30.36

31.73

nmol/l

0.28

213

2110

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

458

2657

1.23

4.24

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

296

1.71

4.23

1.1

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

458

2660

1.23

4.20

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

635

3806

1.19

4.20

1.4

1.6

22.46

35.18

iu/ml

2.12

185

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

239

1.79

4.17

1.3

1.5

49.63

35.23

1.75

159

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

158

1.98

4.17

1.5

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

106

2.22

4.14

1.0

1.1

—

(3013762) Body weight Measured

120

2.13

4.13

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

535

3162

1.21

4.13

3.5

4.9

60.06

111.01

u/ml

2.22

110

1025

(44786800) Granulocytes/100 leukocytes in Body fluid

358

1.63

4.12

1.3

23.50

24.86

0.14

266

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

125

2.11

4.11

1.2

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

460

2681

1.22

4.09

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

460

2683

1.22

4.07

1.2

—

(3014891) Appearance of Pleural fluid

404

1.59

4.05

1.7

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

360

1.62

4.04

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

131

639

1.46

4.03

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

460

2687

1.22

4.01

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

303

1689

1.28

4.01

7.9

5.7

882.37

3388.40

u/ml

0.62

318

(4094501)

1401

8928

1.12

3.94

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

200

1055

1.35

3.94

2.6

3.6

51.67

52.96

0.33

194

1019

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

445

2597

1.22

3.93

2.0

12.68

14.40

1.81

187

1225

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1869

12096

1.10

3.93

1.4

1.5

—

(37019676) Renin [Units/volume] in Plasma --supine

2.56

3.91

1.0

1.1

55.57

57.61

mu/l

0.02

(3013336) Amino acids [Identifier] in Serum or Plasma

2.67

3.87

3.2

2.9

—

(44806071)

100

466

1.53

3.85

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6075

41126

1.06

3.82

1.7

1.8

—

(3024263) Appearance of Synovial fluid

304

1708

1.27

3.80

1.7

1.8

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

231

1.76

3.78

3.7

2.8

93.21

381.67

pmol/l

0.43

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

301

1.66

3.76

1.0

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

289

1617

1.27

3.74

1.3

1.5

3.52

4.11

0.23

385

(3000034) Microalbumin [Mass/volume] in Urine

498

2957

1.20

3.71

3.1

3.0

55.76

56.14

mg/l

0.01

369

2102

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

131

2.01

3.68

1.2

1.3

1.32

1.01

u/field

1.22

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

270

1502

1.28

3.67

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

104

495

1.50

3.65

2.7

2.8

1130.26

1853.62

u/l

0.57

444

(3012898) Urea [Moles/volume] in Urine

337

1.61

3.64

1.6

164.56

169.69

mmol/l

0.15

300

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.64

3.62

1.2

1.1

91.50

106.57

nmol/24h

0.29

(3000285) Sodium [Moles/volume] in Blood

377

1.57

3.60

1.3

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

218

1185

1.31

3.54

1.1

—

(3025130) Human papilloma virus identified in Specimen

838

5211

1.15

3.53

1.7

—

(3044007) Cell count panel - Peritoneal fluid

166

867

1.36

3.53

2.0

1.9

—

(3051101) Glucose [Moles/volume] in Cord blood

586

0.58

3.47

5.6

5.5

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

175

1.83

3.44

1.3

1390.59

888.13

u/l

0.16

155

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

104

502

1.47

3.44

1.0

87.61

80.57

ug/l

0.93

416

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

239

1.70

3.40

1.1

1.2

21.50

23.59

—

(3036670) Protein [Mass/volume] in Synovial fluid

176

934

1.34

3.39

1.2

38.73

40.37

g/l

0.86

518

(3006462) Nitrate [Presence] in Urine

287

1631

1.25

3.31

3.5

3.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

252

1.67

3.30

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

263

1.65

3.30

1.4

1.3

1.24

1.43

ml/s/173m2

0.21

164

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

866

5426

1.14

3.29

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

478

1.47

3.29

1.5

1.4

206854.57

206022.82

nmol/l

0.00

399

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

840

5254

1.14

3.28

1.1

119.23

118.22

0.36

740

4777

(3001964) Herpes simplex virus Ag [Presence] in Specimen

189

1020

1.32

3.27

1.4

1.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

103

2.07

3.27

1.0

—

(4211845)

311

1787

1.24

3.26

3.3

2.9

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

237

1.68

3.25

1.2

16.42

15.14

nmol/l

0.16

(21494434) Karyotype in Bone marrow

445

2658

1.19

3.17

1.1

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

109

541

1.43

3.16

1.2

1.66

1.68

mmol/l

0.06

327

(3047189) Immunofixation for 24 hour Urine

244

1370

1.27

3.14

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

144

751

1.36

3.14

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

334

1.56

3.12

1.1

1.2

—

(3032641) Amino acids panel - Urine

3.28

3.12

1.2

1.5

—

(3033942) Copper [Moles/time] in 24 hour Urine

145

1.86

3.11

1.1

1.2

0.32

0.74

umol/24h

1.11

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

157

832

1.34

3.10

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

817

5125

1.14

3.08

1.3

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

180

1663

0.77

3.03

1.7

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

172

928

1.32

3.01

1.5

1.6

9.78

8.93

ug/l

1.35

172

928

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

153

0.33

2.99

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

233

2081

0.80

2.98

1.0

0.46

0.76

u/ml

0.47

287

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

179

1.75

2.96

1.3

1.4

1.42

1.69

0.11

119

(3002621) Streptococcal DNAse B [Units/volume] in Serum

288

1.58

2.96

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

572

3513

1.16

2.94

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

45686

327647

0.97

2.92

21.2

13.5

39.36

40.04

47.29

30605

246739

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

301

0.47

2.92

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

433

1.46

2.89

2.5

2.6

71.16

71.26

pmol/l

0.00

376

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

101

504

1.43

2.88

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

104

1.98

2.85

1.1

1.2

3320.29

3931.32

ng/l

0.14

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

192

1.71

2.85

1.1

41.63

84.29

u/l

0.67

151

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

489

1.43

2.80

1.1

0.06

0.36

u/ml

1.70

300

(40762814) Titanium [Mass/volume] in Blood

100

501

1.42

2.80

2.2

2.3

3.78

3.65

ug/l

0.07

166

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

222

1253

1.26

2.79

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

148

793

1.33

2.76

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

148

793

1.33

2.76

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

148

793

1.33

2.76

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

148

793

1.33

2.76

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

182

1004

1.29

2.75

1.4

53.68

54.90

0.16

150

865

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

249

1.60

2.74

1.2

99.89

105.21

ug/l

0.09

158

(3051387) C reactive protein [Mass/volume] in Capillary blood

1129

7275

1.11

2.72

4.4

3.2

24.72

26.89

mg/l

1.16

669

4606

(3026470) Cobalt [Mass/volume] in Blood

312

1833

1.21

2.72

1.9

2.0

3.42

3.76

ug/l

0.23

270

1614

(3023436) Glucagon [Mass/volume] in Serum or Plasma

163

1.75

2.70

1.5

1.7

192.69

206.00

ng/l

0.39

140

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

150

808

1.32

2.70

1.3

262.21

264.73

ug/l

0.01

434

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

206

1.66

2.70

1.6

1.3

26.93

14.86

pmol/l

1.08

172

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

422

1.45

2.70

1.8

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

148

796

1.32

2.70

1.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

330

1954

1.20

2.66

2.7

39.14

39.56

0.11

680

(3025577) Chromium [Mass/volume] in Blood

303

1782

1.21

2.63

2.0

2.1

2.28

2.34

ug/l

0.07

246

1498

(3043410) Blood group antigens tested for on Red Blood Cells

170

937

1.29

2.61

2.1

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

862

5490

1.12

2.60

1.3

1.2

3.44

3.93

u/ml

0.69

364

2460

(3044009) aPTT.lupus sensitive (LA screen)

327

1.50

2.59

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.25

2.57

1.2

1.1

2.53

0.00

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

439

1.43

2.55

1.5

1.4

11.28

11.88

0.08

208

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

215

1.62

2.55

1.4

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

199

1.64

2.53

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.85

2.52

1.0

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

205

1.63

2.51

3.1

2.0

12.09

17.23

0.74

101

(4306422)

855

5457

1.12

2.50

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

100

513

1.39

2.49

1.6

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

290

1.52

2.48

1.0

1.1

7.60

3.86

u/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

383

1.45

2.47

2.5

2.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

214

1223

1.25

2.46

1.8

2.0

166.94

164.74

0.10

206

1151

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

276

1621

1.21

2.45

1.1

98.82

97.33

0.31

213

1300

(43055442) Apixaban [Mass/volume] in Serum or Plasma

390

1.44

2.44

1.5

1.6

106.78

111.74

ug/l

0.16

321

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

213

1.60

2.41

1.0

—

(3002619) Bacteria identified in Specimen by Culture

129

693

1.32

2.41

1.3

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

191

1.64

2.41

1.4

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

230

1.58

2.40

2.9

2.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

687

4342

1.13

2.40

1.3

1.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

186

1.65

2.39

1.1

1.28

3.07

u/l

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

197

1.63

2.39

1.0

0.10

0.57

u/ml

1.66

182

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

253

1.55

2.38

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

282

1.51

2.37

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

269

2303

0.83

2.37

1.0

2.59

2.22

u/ml

0.10

550

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

341

1.46

2.33

3.3

2.9

1.22

1.29

mg/l

0.14

237

(3045683) HLA typing for celiac disease panel - Blood or Tissue

361

2189

1.17

2.28

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

302

1.48

2.28

1.1

21.62

20.15

u/l

0.19

196

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

373

2274

1.17

2.22

1.1

1.08

1.07

ratio

0.64

137

799

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.95

2.21

1.3

1.6

101.93

124.86

ug/l

0.35

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.56

2.20

1.0

1.1

27.50

31.12

umol/l

—

(3037556) Urate [Mass/volume] in Serum or Plasma

160

900

1.27

2.16

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.23

2.15

1.1

1.2

—

(4133840)

111

1036

0.76

2.14

1.2

—

(3045142) Bone marrow Pathology biopsy report

544

3419

1.13

2.12

1.2

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

127

1.74

2.12

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

258

1531

1.20

2.12

1.3

1.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

250

1.51

2.09

1.1

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

117

1.76

2.09

2.5

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

385

2367

1.16

2.08

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

255

1515

1.20

2.07

28.3

27.9

121.56

116.28

ug/l

0.50

209

1258

(36303858) Crystals [Presence] in Urine

2.32

2.04

1.1

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

187

1079

1.23

2.04

1.1

1.0

7.11

10.65

u/ml

0.85

149

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.83

2.04

1.1

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

257

1531

1.20

2.04

1.3

1.5

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.94

2.02

1.0

0.18

0.63

u/ml

1.15

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

130

720

1.29

2.01

1.4

26.68

22.02

0.94

108

597

(3022475) Manganese [Moles/volume] in Blood

207

1.55

2.00

1.2

1.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.15

1.98

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

874

5675

1.10

1.92

1.3

1.2

3.39

3.72

u/ml

0.20

271

1975

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

129

1160

0.79

1.89

1.0

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

3.88

1.89

1.2

1.0

0.00

4.00

u/l

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.97

1.82

1.3

2.5

2.01

2.15

mu/l

0.05

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

128

1.67

1.82

1.1

2.33

0.96

u/field

0.56

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

196

1.52

1.79

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

268

1625

1.17

1.78

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

856

5577

1.09

1.78

1.1

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.84

1.77

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

3.11

1.75

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

433

0.67

1.74

6.2

1.4

7.31

7.34

mmol/l

0.02

154

(3025315) Body weight

291

1.42

1.74

4.4

4.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

186

1.53

1.74

1.0

—

(3019174) dRVVT (LA screen)

321

1.40

1.73

1.1

1.2

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.80

1.73

4.2

6.3

0.81

1.39

mg/l

1.81

(3007916) DNA double strand Ab [Titer] in Serum

432

1.33

1.69

1.2

1.4

46.80

149.39

titre

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

124

701

1.26

1.68

2.4

2.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

283

2331

0.86

1.68

1.0

1.1

3.75

2.20

u/ml

0.23

643

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.25

1.66

2.3

2.4

—

(3046861) Legionella sp Ag [Presence] in Urine

172

1.53

1.62

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

171

1464

0.83

1.62

1.6

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

242

1.44

1.62

3.8

2.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

131

751

1.24

1.60

1.2

1.1

69.06

78.19

0.75

200

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

237

1.44

1.59

5.1

5.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

468

1.31

1.59

3.5

2.9

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

145

1.57

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

556

4370

0.90

1.56

1.1

1.0

0.29

0.52

u/ml

0.88

123

918

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1837

12380

1.06

1.54

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

157

923

1.21

1.52

1.4

1.3

4.06

3.41

mmol/l

1.23

140

849

(3011325) HIV 1+2 Ab [Presence] in Serum

175

1.50

1.52

1.1

1.0

—

(3018133) Calcium [Moles/volume] in Urine

498

1.29

1.49

1.7

1.8

2.52

2.70

mmol/l

0.36

448

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

525

1.27

1.45

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.37

1.44

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

599

3889

1.10

1.42

1.2

1.1

96.72

95.58

0.47

549

3650

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

130

757

1.22

1.41

1.2

87.42

89.81

0.19

213

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

135

790

1.22

1.40

1.2

1.3

114.08

107.24

1.47

127

747

(3007461) Platelets [#/volume] in Blood

55407

393067

1.03

1.37

30.1

18.6

256.53

252.24

e9/l

41.76

54158

383136

(40765089) Chromosome analysis panel - Blood by G-banded

143

1220

0.83

1.36

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

375

1.31

1.33

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

175

1.46

1.33

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

140

828

1.20

1.32

1.1

—

(3004775) Volume in Urine collected for unspecified duration

408

2611

1.11

1.31

2.1

2.3

736.62

667.09

2.04

281

1785

(3042628) Porphyrins [Moles/volume] in Urine

2.96

1.31

1.2

1.0

—

(40768795) Lymph node Pathology biopsy report

501

3241

1.10

1.30

1.2

—

(40765096) Chromosome analysis panel by Banding

149

888

1.19

1.30

1.2

1.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.73

1.30

1.0

—

1.08

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

250

1554

1.15

1.29

2.1

101.49

100.45

ug/min

0.01

361

(3015183) Erythrocyte sedimentation rate

238

1937

0.87

1.27

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

699

5376

0.92

1.27

1.1

3.63

4.62

u/ml

0.75

270

2100

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.64

1.27

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

100

576

1.24

1.1

1.3

62.17

170.12

titre

1.13

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

167

1.45

1.21

1.0

1.2

—

(4268621)

571

3735

1.09

1.20

2.4

2.3

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

1.19

0.0

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

1.19

0.0

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

168

1022

1.17

1.18

1.1

2.17

6.27

u/ml

0.61

564

(4212803)

271

1.34

1.18

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

302

1.32

1.17

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

290

1.33

1.16

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

229

1.37

1.16

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

278

1.33

1.16

1.1

18.15

17.13

g/l

0.40

250

(3011897) Casein IgE Ab [Units/volume] in Serum

550

1.23

1.14

1.1

1.2

11.17

5.88

u/ml

0.25

123

(3042301) Urate [Moles/volume] in Synovial fluid

1.75

1.14

1.0

353.14

360.26

umol/l

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

250

1571

1.13

1.14

2.0

2.2

20.23

197.30

ug/l

1.84

238

1502

(3042010) Triglyceride [Moles/volume] in Pleural fluid

442

1.26

1.13

1.3

1.76

1.27

mmol/l

0.31

276

(40763590) HLA-DQ beta [Type]

123

1.50

1.12

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

2.54

1.12

1.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

2.54

1.12

1.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.78

1.12

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

106

1.54

1.11

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

162

989

1.17

1.11

1.7

2.1

185.48

824.58

e6/l

1.48

517

(40760409) HLA-A [Type] by High resolution

124

1.49

1.09

1.0

—

(40760410) HLA-B [Type] by High resolution

124

1.49

1.09

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

238

1.35

1.09

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

325

1.29

1.08

1.2

1.3

6.04

6.16

mmol/l

0.05

162

(3013247) Albumin in CSF/Albumin in Serum or Plasma

131

788

1.18

1.08

1.1

6.56

7.12

mg/g

0.38

124

749

(3026250) Tacrolimus [Mass/volume] in Blood

249

1571

1.13

1.08

34.4

36.6

7.22

7.40

ug/l

0.70

227

1430

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

311

1988

1.11

1.08

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

166

1.41

1.07

1.5

189.07

178.34

ug/g

0.13

141

(3023430) Cat dander IgE Ab [Units/volume] in Serum

662

5058

0.93

1.07

1.1

4.94

4.72

u/ml

0.10

288

2065

(46236302) HLA-C [Type] by High resolution typing

125

1.48

1.06

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

795

6032

0.94

1.05

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

102

1.53

1.05

1.0

—

(3013862) HLA-DP [Type]

126

1.47

1.02

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.08

1.02

1.0

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

156

1.41

1.01

1.0

0.09

0.15

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

482

1.23

1.00

1.6

—

(3004959) Base excess in Arterial cord blood by calculation

114

0.56

1.00

1.0

1.1

—

-0.39

—

(3007733) Chloride [Moles/volume] in Urine

1.61

0.99

1.1

1.5

114.75

82.58

mmol/l

0.90

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

438

1.23

0.99

1.1

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

368

1.26

0.99

1.4

70.63

71.59

0.09

305

(3034092) Cytoplasmic Ig cells/100 cells in Blood

488

0.79

0.97

19.9

6.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

798

6032

0.94

0.96

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

105

1.49

0.94

1.5

1.7

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.87

0.94

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

2.25

0.94

1.0

—

(3036603) Volume of Urine

353

2293

1.10

0.93

1.5

1.7

1833.82

1956.37

0.60

557

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.54

0.93

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

260

1665

1.11

0.91

1.1

1617.15

1508.78

miu/ml

0.79

260

1665

(3035941) MCH [Entitic mass]

55413

393380

1.02

0.91

29.9

18.5

30.34

30.25

25.92

54561

388217

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

379

1.24

0.91

1.3

36.94

262.58

u/l

1.15

271

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

624

0.82

0.90

4.5

5.5

—

(3008037) Lactate [Moles/volume] in Venous blood

1040

7036

1.05

0.88

3.6

3.1

1.58

mmol/l

0.04

1015

6896

(3024316) Viscosity of Plasma

161

1.37

0.88

1.6

1.8

1.77

1.65

mpas

0.34

(3038177) Helicobacter pylori Ab [Presence] in Serum

893

6019

1.06

0.87

1.3

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.71

0.87

1.1

1.3

—

(3024731) MCV [Entitic volume]

55416

393433

1.02

0.86

30.0

18.5

91.24

90.71

135.52

54564

388258

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

208

1322

1.12

0.85

1.8

2.1

29.67

29.18

0.19

196

1249

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

995

7439

0.95

0.85

1.1

0.95

1.63

u/ml

2.42

399

2975

(3008401) Mugwort IgE Ab [Units/volume] in Serum

848

6366

0.95

0.84

1.1

0.67

1.16

u/ml

3.36

345

2644

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

138

1.39

0.84

7.6

9.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

327

0.76

0.84

1.5

1.6

—

(3026361) Erythrocytes [#/volume] in Blood

55417

393468

1.02

0.82

30.1

18.5

4.43

4.52

e12/l

307.65

54009

382476

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

257

1.27

0.81

1.0

1.1

13.64

18.40

iu/ml

0.20

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1774

12174

1.04

0.81

1.3

208.96

224.28

miu/ml

0.90

648

5787

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.81

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.54

0.80

5.7

5.3

0.22

0.25

mmol/l

0.20

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.80

0.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

830

6223

0.95

0.80

1.1

1.20

2.29

u/ml

2.83

205

1537

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

218

0.72

0.78

1.1

4.60

7.13

u/ml

0.62

157

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

177

1.33

0.78

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.74

0.77

1.1

1.0

—

(3041184) Isoniazid [Presence] in Urine

1.73

0.76

2.3

2.5

—

(3022689) Creatine [Moles/volume] in Urine

150

943

1.13

0.76

1.6

1.4

—

(3010813) Leukocytes [#/volume] in Blood

55423

393549

1.02

0.76

30.2

18.6

7.00

6.70

e9/l

132.37

54022

382562

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

2.09

0.74

1.2

1.1

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

2.09

0.74

1.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.09

0.74

1.2

1.1

—

(3006598) pH of Arterial cord blood

115

0.62

0.74

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

306

1.23

0.73

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

581

3896

1.06

0.72

2.8

2.4

—

(3024932) HLA-DR beta [Type]

185

1183

1.11

0.72

1.2

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

180

1.30

0.72

1.0

1.2

—

303.33

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

137

1.35

0.71

1.2

0.08

0.07

g/l

0.16

100

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

130

0.66

0.70

1.0

0.00

0.48

u/ml

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

478

1.18

0.69

1.9

2.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

577

1.16

0.69

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

899

6690

0.96

0.68

1.1

4.32

5.20

u/ml

1.03

451

3393

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

330

1.21

0.66

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

338

2235

1.08

0.66

1.1

8.52

8.39

iu/ml

0.03

586

(3024471) HLA-A [Type]

188

1212

1.10

0.65

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

1.78

0.65

1.2

16.38

32.69

nmol/24h

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

370

1.19

0.65

1.0

0.17

0.18

u/ml

0.07

219

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

495

1.16

0.64

1.8

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

55418

393601

1.02

0.64

30.3

18.6

133.53

136.02

g/l

292.25

54558

388478

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

225

0.76

0.63

1.1

1.3

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

118

0.66

0.62

1.0

0.10

0.95

u/ml

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

217

1684

0.92

0.62

1.2

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.0

—

0.09

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

141

1.31

0.61

1.0

0.11

0.07

u/ml

—

(3006245) CD3-CD19+ cells/100 cells in Blood

208

1354

1.09

0.61

1.8

2.2

9.77

10.20

0.25

192

1254

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

112

705

1.13

0.60

1.8

1.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

117

0.67

0.60

2.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.78

0.59

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

133

0.70

0.59

1.0

0.02

0.28

u/ml

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

190

1476

0.92

0.57

1.2

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

336

1.19

0.57

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

531

0.86

0.57

6.5

7.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.52

0.55

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.52

0.55

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.52

0.55

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.52

0.55

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.52

0.55

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.52

0.55

1.4

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.52

0.55

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.52

0.55

2.0

—

(3009677) Dengue virus Ab [Presence] in Serum

144

1.28

0.54

1.0

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.45

0.53

2.0

2.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.52

0.52

1.2

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

741

5064

1.04

0.50

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

108

689

1.12

0.50

1.3

1.2

59.26

42.68

mg/l

0.14

498

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

217

1.21

0.49

1.0

0.13

1.83

u/ml

1.52

167

(3019768) Coxiella burnetii Ab [Presence] in Serum

198

1.22

0.49

1.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

1146

8409

0.97

0.48

5.1

3.9

—

(40763791) Oxygen content in Venous blood by calculation

1.34

0.48

4.1

7.8

11.47

12.37

ml/dl

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

136

882

1.10

0.47

1.9

2.0

32.34

38.42

u/l

0.20

125

792

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

422

2853

1.05

0.47

1.4

1.3

65.73

116.26

pmol/l

0.95

183

885

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

524

1.13

0.47

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

110

0.71

0.46

2.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.33

0.46

1.0

—

(3003577) Lead [Moles/volume] in Blood

283

0.83

0.45

1.2

1.4

0.15

0.23

umol/l

0.97

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

233

1.19

0.45

1.0

0.05

0.82

u/ml

1.09

147

(3034426) Prothrombin time (PT)

184

1215

1.08

0.44

1.3

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

201

1.20

0.43

4.4

5.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.46

0.43

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

234

1.19

0.43

4.6

4.5

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.62

0.43

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.42

0.43

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

108

698

1.10

0.42

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

108

698

1.10

0.42

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.39

0.42

1.0

1.1

146.59

141.84

mmol/24h

—

(3027035) Albumin [Mass/time] in 24 hour Urine

321

1.15

0.42

1.5

1.3

399.74

334.11

mg/24h

—

(4038314)

271

0.84

0.40

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

346

2341

1.05

0.40

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

336

1.14

0.40

1.9

2.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

110

715

1.09

0.39

2.9

2.6

114.84

99.12

ng/l

0.30

354

(3009992) Blasts/100 cells in Bone marrow

1.42

0.39

1.2

1.8

21.60

17.24

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

954

6985

0.97

0.39

1.7

1.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.36

0.38

1.1

1936.67

2053.62

titre

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

33530

239301

0.99

0.38

3.3

3.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

398

1.13

0.38

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

107

697

1.09

0.37

1.3

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

400

1.12

0.35

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

456

0.89

0.35

1.1

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

213

1.17

0.35

3.7

2.6

21.51

14.48

0.96

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

190

1437

0.94

0.35

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.38

0.35

1.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.29

0.33

1.2

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

666

4881

0.97

0.32

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

242

1.15

0.32

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.31

0.31

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

595

1.09

0.31

1.1

1.14

4.50

u/ml

1.63

418

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.76

0.31

1.0

0.08

0.07

u/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

216

1.15

0.31

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

117

1.22

0.30

1.1

208.27

275.78

nmol/l

1.67

117

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

202

0.85

0.30

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

199

1494

0.95

0.30

1.2

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.28

0.30

1.0

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.28

0.30

1.0

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

172

1295

0.94

0.29

2.0

1.9

8.66

9.32

mg/l

0.84

148

1028

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.25

0.29

1.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.73

0.29

1.0

1.5

2.08

2.16

mmol/24h

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.26

0.28

1.1

1.0

0.01

0.19

u/ml

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

324

2398

0.96

0.28

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

721

0.93

0.28

1.0

1.1

1.50

2.20

u/ml

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

115

0.80

0.27

1.0

0.15

0.12

u/ml

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.27

0.26

1.1

1.3

0.68

7.37

mg/l

2.70

(3035611) Eosinophils/100 leukocytes in Synovial fluid

226

1.13

0.26

1.5

1.7

0.65

0.72

0.11

175

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

176

0.85

0.26

1.0

1.1

—

(44806420)

127

850

1.06

0.26

2.1

2.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.28

0.25

1.2

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

228

0.87

0.25

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

118

789

1.06

0.25

1.2

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

466

0.92

0.25

1.2

1.3

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.37

0.24

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.32

0.23

2.2

2.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

447

1.08

0.23

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

195

1.13

0.23

1.0

1.2

1.66

3.84

u/ml

0.47

163

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

211

0.88

0.23

1.0

28.39

14.98

u/ml

0.32

175

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

128

862

1.06

0.23

1.3

38.60

38.73

0.01

584

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.81

0.22

2.4

3.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

634

1.07

0.22

1.9

1.8

2.20

3.55

ug/l

0.81

381

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.20

0.21

10.7

8.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

390

2697

1.03

0.21

1.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

177

1.13

0.20

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.25

0.19

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

230

0.90

0.19

1.4

1.5

354.59

323.32

umol/24h

0.21

230

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

502

3491

1.02

0.19

1.3

1.4

12.14

11.79

mmol/l

0.33

177

770

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

205

1.11

0.19

1.1

1.0

—

(3042733) HLA Ab [Presence] in Serum

180

1233

1.04

0.18

4.3

5.1

—

(40758358) Immune stain study

145

1.13

0.17

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.74

0.17

1.0

1.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.19

0.17

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

101

0.85

0.17

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

200

1.10

0.16

1.1

33.58

31.66

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

200

1.10

0.16

1.1

22.86

24.27

u/ml

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

393

1.07

0.16

1.9

1.7

1.67

1.69

mg/l

0.04

329

(3036312) Salmon IgE Ab [Units/volume] in Serum

220

0.91

0.16

1.0

1.1

2.78

0.71

u/ml

0.71

150

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.17

0.16

10.6

8.2

41.86

44.31

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

702

0.95

0.16

10.6

8.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

192

1410

0.97

0.15

3.0

3.1

8.49

7.87

mg/l

0.56

150

1130

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.12

0.15

6.2

3.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

301

2089

1.03

0.15

5.4

6.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

738

5330

0.98

0.15

1.8

2.1

6.43

6.73

umol/l

0.20

526

3872

(3035933) Granulocytes/100 leukocytes in Blood

132

975

0.96

0.14

3.8

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

311

2164

1.02

0.13

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

286

1.07

0.13

1.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

176

1.09

0.12

13.2

9.7

242.84

306.02

e6/l

0.16

130

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

135

1.11

0.12

1.4

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

155

1136

0.97

0.12

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

567

3977

1.01

0.11

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

266

0.94

0.11

1.7

3.3

1.94

2.24

mg/l

0.52

227

(3026726) Creatinine [Moles/volume] in Specimen

275

1.06

0.10

2.2

2.5

722.88

322.05

umol/l

0.49

265

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

373

1.05

0.10

2.4

25.29

22.31

mg/l

0.65

354

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

137

1.09

0.10

23.2

14.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

167

1160

1.02

0.09

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

179

1.07

0.09

4.2

3.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

143

1042

0.98

0.08

1.7

161.14

129.90

au/ml

0.23

135

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

610

0.97

0.08

1.1

—

(3020650) Glucose [Presence] in Urine

139

966

1.02

0.08

1.6

1.4

—

(3029612) Listeria sp Ab [Titer] in Serum

1.12

0.08

1.6

1.3

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.12

0.08

1.0

1.1

0.02

0.06

g/l

—

(3016031) Almond IgE Ab [Units/volume] in Serum

241

0.94

0.08

1.1

1.0

0.07

0.69

u/ml

4.15

137

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

551

1.03

0.08

1.2

1.5

5.28

6.30

nmol/l

0.65

525

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

348

1.04

0.08

1.1

1.0

0.07

0.42

u/ml

1.19

192

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

327

1.04

0.08

1.0

0.15

1.66

u/ml

1.52

245

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

743

5331

0.99

0.07

1.1

2.42

2.97

u/ml

0.68

286

2685

(3020356) Listeria sp identified in Specimen by Organism specific culture

262

0.95

0.07

1.2

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

160

1.07

0.07

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

603

4252

1.01

0.07

2.4

2.5

—

(40762887) Creatinine [Moles/volume] in Blood

1.12

0.06

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

292

2051

1.01

0.06

1.3

1.4

5.84

5.57

mmol/l

3.68

273

1940

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

261

0.95

0.06

1.4

1.3

23.57

21.35

mmol/l

1.39

190

(3038515) Glucose [Moles/volume] in Venous blood

942

6660

1.01

0.06

3.8

3.2

7.44

7.57

mmol/l

0.64

920

6544

(40768446) Kidney Pathology biopsy report

198

1429

0.99

0.06

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

365

1.03

0.05

2.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.09

0.05

1.1

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

331

1.03

0.05

1.0

0.14

1.60

u/ml

2.16

246

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

201

0.96

0.04

1.4

2.1

—

(3001729) Color of Synovial fluid

268

1.04

0.04

1.4

1.6

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

360

1.03

0.04

1.1

1.0

0.51

1.39

u/ml

0.39

194

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

148

1039

1.01

0.04

1.2

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

193

0.96

0.04

1.0

1.1

0.63

9.92

u/ml

0.49

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

182

1284

1.01

0.02

2.4

2.6

183.11

140.56

au/ml

0.56

176

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

129

1.05

0.02

1.3

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

412

1.02

0.02

7.9

0.34

0.40

umol/l

0.36

372

(3000330) Specific gravity of Urine by Test strip

2322

16501

1.00

0.01

3.8

3.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

504

0.99

0.01

2.8

2.4

—

(40758292) HTLV I+II Ab panel - Serum

575

0.99

0.01

1.3

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

154

0.97

0.01

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

112

801

0.99

0.00

10.3

8.6

—

(3018001) Oat IgE Ab [Units/volume] in Serum

252

1.02

0.00

1.0

0.12

1.07

u/ml

0.83

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.99

0.00

2.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.99

0.00

1.0

1.1

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.00

0.00

1.1

1.2

24.40

28.65

mg/l

—

(3009871) Measles virus Ab [Titer] in Serum

172

1223

1.00

0.00

1.7

—

(3007700) Barley IgE Ab [Units/volume] in Serum

170

1.00

0.00

1.0

0.06

8.75

u/ml

0.54

(3025886) Oxalate [Mass/time] in 24 hour Urine

100

1.00

0.00

1.0

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

329

0.99

0.00

1.1

1.0

0.08

0.51

u/ml

1.88

183

(3034614) HLA Ag [Interpretation]

1.03

0.00

1.3

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.93

0.00

1.0

1.1

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.6

—

4.08

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

0.0

1.0

—

12.46

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3035109) Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

1.00

0.00

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.93

0.00

2.2

3.5

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.94

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_BZD – Benzodiazepine use

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benzodiazepine use

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Benzodiazepine use (RX_BZD)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints